Common Neoplasms

  • Samuel P. Hammar


Lung cancer remains the most frequently diagnosed malignant neoplasm throughout the world and is the number one cause of cancer death in the American male and female. It is responsible for about 25% of all cancer deaths1 and about 6% of all deaths in the United States.2 Since 1930, more people have died from lung cancer than all other types of cancer combined.3 An estimated 161,000 will be diagnosed in the United States in 1991 with an approximate 143,000 deaths.4


Carcinoid Tumor Small Cell Carcinoma Squamous Carcinoma Atypical Carcinoid Bronchial Carcinoid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jett JR, Cortese DA, Fonatana RS. Lung cancer: Current concepts. Ca-A Cancer J Clin 1983; 33: 74–86.CrossRefGoogle Scholar
  2. 2.
    Silverberg E, Lubera JA. Cancer statistics. Ca-A Cancer J Clin Bull Cancer Prog 1989; 39: 3–20.CrossRefGoogle Scholar
  3. 3.
    Silverberg E, Lubera J. Cancer statistics, 1987. Ca-A Cancer J Clin 1987; 37: 2–19.CrossRefGoogle Scholar
  4. 4.
    American Cancer Society. Cancer facts and figures, 1991 Atlanta: American Cancer Society, 1991: 8.Google Scholar
  5. 5.
    Robbins SL. The respiratory system. In: Pathologic basis of disease. Philadelphia: Saunders, 1974: 833–840.Google Scholar
  6. 6.
    Galofre M, Payne WS, Woolner LB, Claggett OT, Gage RP. Pathologic classification and surgical treatment of bronchogenic carcinoma. Surg Gynecol Obstet 1964; 119: 51–61.PubMedGoogle Scholar
  7. 7.
    Selawry OS, Hansen HH. Lung cancer. In: Holland JF, Frei E, eds. Cancer medicine. Part 2. Philadelphia: Lea and Febiger, 1973: 1473–1518.Google Scholar
  8. 8.
    Garfinkel L, Silverberg E. Lung cancer smoking trends in the United States over the past 25 years. Ca-A Cancer J Clin 1991; 41: 137–165.CrossRefGoogle Scholar
  9. 9.
    Devesa SS, Blot WJ, Fraumeni JF, Jr. Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst 1989; 81: 1568–1571.PubMedCrossRefGoogle Scholar
  10. 10.
    Glass A. Declining rates of lung cancer in the United States in young men and women. J Natl Cancer Inst 1991; 83: 368–369.PubMedCrossRefGoogle Scholar
  11. 11.
    Parkin DM, Sternsward J, Muir CS. Estimates of twelve major cancers. Inst WHO 1984; 62: 163–182.Google Scholar
  12. 12.
    Cancer Incidence in Five Continents. NYS Med 1989; 92: 432–433.Google Scholar
  13. 13.
    Patterns of cancer incidence in five continents: A picture book. Whelan SL, Parkin DM, Masuyer E, eds. IARC Sci Publ *102, Lyon; IARC, 1990: 25.Google Scholar
  14. 14.
    Napalkov NP. Incidence of malignant tumors in the USSR between 1970 and 1980. Voprosky Onkologii 1982; 28: 26–27.Google Scholar
  15. 15.
    Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: Twenty two years’ observations on female British doctors. Br Med J 1980; 280: 428–429.CrossRefGoogle Scholar
  16. 16.
    Pollack ES, Horm JW. Trends in cancer incidence and mortality in the United States 1969–1976. J Natl Cancer Inst 1980; 64: 1091–1103.PubMedGoogle Scholar
  17. 17.
    Hoick SE, Warren CW, Rochat RW, Smith JC. Lung cancer mortality and smoking habits: Mexican-American women. Am J Public Health 1982; 72: 38–42.CrossRefGoogle Scholar
  18. 18.
    Lam Wk, So SY, Yu DYC. Clinical features of bronchogenic carcinoma in Hong Kong: Review of 480 patients. Cancer (Philadelphia) 1983; 52: 369–376.Google Scholar
  19. 19.
    Stolley PD. Lung cancer in women: Five years later, situation worse. N Engl J Med 1983; 309: 428–429.PubMedCrossRefGoogle Scholar
  20. 20.
    L’Able KA, Hoey JR. Cigarette smoking, lung cancer and Canadian women. Can Med Assoc J 1984; 130: 1539–1540.Google Scholar
  21. 21.
    Harris J. Lung cancer among women: Tennessee. Morb Mortal Wkly Rep 1984; 33: 586–588.Google Scholar
  22. 22.
    Wu AH, Henderson BE, Pike MC, Yu MC. Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst 1985; 74: 747–751.PubMedGoogle Scholar
  23. 23.
    Stolley PD. Lung cancer: unwanted equality for women. N Engl J Med 1977; 297: 886–887.PubMedCrossRefGoogle Scholar
  24. 24.
    Lung cancer among women. JAMA 1984; 252: 2806–2811.CrossRefGoogle Scholar
  25. 25.
    Staryzk PM. Lung-cancer deaths: Equality by 2000? N Engl J Med 1983; 309: 1289–1290.Google Scholar
  26. 26.
    Andrews JL, Bloom S, Balogh K, Beamis JF. Lung cancer in women: Lahey clinic experience 1957–1980. Cancer (Philadelphia) 1985; 55: 2894–2898.CrossRefGoogle Scholar
  27. 27.
    Guinee V, Giocco G, Suarez L, et al. Lung cancer and breast cancer among women: Texas. JAMA 1984; 251: 2915–2916.CrossRefGoogle Scholar
  28. 28.
    Chen VW. Lung cancer: Leading cause of cancer death in Louisiana white females. J Natl Cancer Inst 1984; 73: 1–2.Google Scholar
  29. 29.
    McDuffie HH, Klaassen DJ, Dosman JA. Female-male differences in patients with primary lung cancer. Cancer (Philadelphia) 1987; 59: 1825–1830.CrossRefGoogle Scholar
  30. 30.
    Osann KE. Lung cancer in women: The importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 1991; 51: 4893–4897.PubMedGoogle Scholar
  31. 31.
    Anderson AE, Buechner HA, Yoger I, Ziskind MM. Bronchogenic carcinoma in young men. Am J Med 1954; 16: 404 415.Google Scholar
  32. 32.
    Neuman HW, Ellis FH, McDonald JR. Bronchogenic carcinoma in persons under forty years of age. N Engl J Med 1956; 254: 502–507.PubMedCrossRefGoogle Scholar
  33. 33.
    Rivkin LM, Salyer JM. Bronchogenic carcinoma in men under 40 years of age. Chest 1958; 34: 521–524.CrossRefGoogle Scholar
  34. 34.
    Hanbury WJ. Bronchogenic carcinoma in young persons. Br J Cancer 1958; 12: 202–206.PubMedCrossRefGoogle Scholar
  35. 35.
    Large SE, Morgan WKC. Bronchial carcinoma in young adults. Br J Tuberc 1958; 52: 185–189.CrossRefGoogle Scholar
  36. 36.
    Hood RH, Campbell DC, Dooley BN. Bronchogenic carcinoma in young people. Dis Chest 1965; 48: 469–470.PubMedCrossRefGoogle Scholar
  37. 37.
    Kennedy A. Lung cancer in young adults. Br J Dis Chest 1972; 66: 147–154.PubMedCrossRefGoogle Scholar
  38. 38.
    Kyniakos M, Webber B. Cancer of the lung in young men. J Thorac Cardiovasc Surg 1974; 67: 634–648.Google Scholar
  39. 39.
    Putnam JS. Lung carcinoma in young adults. JAMA 1977; 238: 35–36.PubMedCrossRefGoogle Scholar
  40. 40.
    Ganz PA, Vernon SE, Preston D, Coulson WF. Lung cancer in younger patients. West J Med 1980; 133: 373–378.PubMedGoogle Scholar
  41. 41.
    DeCaro L, Benfield JR. Lung cancer in young persons. J Thorac Cardiovasc Surg 1982; 83: 372–376.PubMedGoogle Scholar
  42. 42.
    Roviaro GC, Varoli F, Zannini P, Fascianella A, Pezzuoli G. Lung cancer in the young. Chest 1985; 87: 456–459.PubMedCrossRefGoogle Scholar
  43. 43.
    McDuffie HH, Klaassen DJ, Dosman JA. Characteristics of patients with primary lung cancer diagnosed at age 50 years or younger. Chest 1989; 96: 1298–1301.PubMedCrossRefGoogle Scholar
  44. 44.
    Jubelirer SJ, Wilson RA. Lung cancer in patients younger than 40 years of age. Cancer (Philadelphia) 1991; 67: 1436–1438.CrossRefGoogle Scholar
  45. 45.
    Bourke W, Milstein D, Giura R, et al. Lung cancer in young adults. Chest 1992; 102: 1723–1729.PubMedCrossRefGoogle Scholar
  46. 46.
    Fontenelle LJ. Primary adenocarcinoma of the lung in a child: Review of the literature. Am Surg 1976; 42: 296–299.PubMedGoogle Scholar
  47. 47.
    Hartman GE, Shochat SJ. Primary pulmonary neoplasms of childhood: A review. Ann Thorac Surg 1983; 36: 108–119.PubMedCrossRefGoogle Scholar
  48. 48.
    Cayley Ck, Caez HJ, Mersheimer W. Primary bronchogenic carcinoma of the lung in children. Am J Dis 32. Common Neoplasms 1265 Child 1951; 82: 49–60.Google Scholar
  49. 49.
    Niitu Y, Kubota H, Hasegawa S, et al. Lung cancer (squamous cell carcinoma) in adolescence. Am J Dis Child 1974; 127: 108–110.PubMedGoogle Scholar
  50. 50.
    LaSalle RJ, Andrassy RJ, Stanford W. Bronchogenic squamous carcinoma in childhood: A case report. J Pediatr Surg 1977; 12: 519–521.CrossRefGoogle Scholar
  51. 51.
    Epstein DM, Aronchick JM. Lung cancer in childhood. Med Pediatr Oncol 1989; 17: 510–513.PubMedCrossRefGoogle Scholar
  52. 52.
    McAldowie AM. Primary cancer of the lungs in a child five and a half months old. Lancet 1876;ii:570–571.Google Scholar
  53. 53.
    Fielding JE. Smoking: health effects and control. N Engl J Med 1985;313: 491–498, 555–561.Google Scholar
  54. 54.
    Kabat GC, Wynder EL. Lung cancer in nonsmokers. Cancer (Philadelphia) 1984; 53: 1214–1221.CrossRefGoogle Scholar
  55. 55.
    Ochsner A, DeBakey M. Carcinoma of the lung. Arch Surg 1941; 42: 209–258.CrossRefGoogle Scholar
  56. 56.
    Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. A study of six hundred and eight four proved cases. JAMA 1950; 143: 329–336.CrossRefGoogle Scholar
  57. 57.
    Hammond EC, Horn D. Smoking and death rates: report on forty-four months of follow-up of 187,783 men. JAMA 1958; 166: 1294–1308.CrossRefGoogle Scholar
  58. 58.
    Rogot E, Murray JL. Smoking and cause of death among American veterans: 16 years of observation. Public Health Rep 1980; 3: 213–222.Google Scholar
  59. 59.
    Pollin W, Ravenholt RT. Tobacco addiction and tobacco mortality. JAMA 1984; 252: 2849–2854.PubMedCrossRefGoogle Scholar
  60. 60.
    Guyatt GH, Newhouse MT. Are active and passive smoking harmful? Determining causation. Chest 1985; 88: 445–451.PubMedCrossRefGoogle Scholar
  61. 61.
    Shopland DR, Eyre HJ, Pechacek TF. Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 1991; 83: 1142–1148.Google Scholar
  62. 62.
    Peto R, Doll R. Mortality in relation to smoking: 20 years’ observations oh male British doctors. Br Med J 1976; 1525–1536.Google Scholar
  63. 63.
    U.S. Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 years of Progress. A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. OHSH Publication No. (CDC) 89–8411, 1989:Google Scholar
  64. 64.
    Center for Disease Control, Public Health Service, U.S. Department of Health and Human Services. The Health consequences of involuntary smoking. A report of the Surgeon General. DHHS Publ. No. 87–8398. Washington, DC: U.S. Govt. Print Office, 1986.Google Scholar
  65. 65.
    National Academy of Sciences. Environmental tobacco smoke: Measuring exposures and assessing health effects. Washington, DC: National Academy Press, 1986.Google Scholar
  66. 66.
    U.S. Environmental Protection Agency. Health effects of passive smoking: Assessment of lung cancer in adults and respiratory disorders in children. Washington, DC: U.S. Environmental Protection Agency, 1990.Google Scholar
  67. 67.
    Janerich DT, Thompson D, Varela LR, et al. Lung cancer and exposure to tobacco smoke in the household. N Engl J Med 1990; 323: 632–636.PubMedCrossRefGoogle Scholar
  68. 68.
    Kozlowski LT. Tar and nicotine delivery of cigarettes. What a difference a puff makes. JAMA 1981; 245: 158–159.Google Scholar
  69. 69.
    Benowitz NL, Hall SM, Herning RI, Jacobs P III, Jones RT, Osman AL. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 1983; 309: 139–142.PubMedCrossRefGoogle Scholar
  70. 70.
    Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955–1960 vs. 1970–1977. N Engl J Med 1979; 300: 381–386.PubMedCrossRefGoogle Scholar
  71. 71.
    Lee PN, Garfinkel L. Mortality and type of cigarette smoked. J Epidemiol Community Health 1981; 35: 1622.CrossRefGoogle Scholar
  72. 72.
    Zang EA, Wynder EL. Cumulative tar exposure: A new index for estimating lung cancer risk among cigarette smokers. Cancer (Philadelphia) 1992; 70: 69–76.CrossRefGoogle Scholar
  73. 73.
    Winters TH, DiFranza JR. Radioactivity in cigarette smoke. N Engl J Med 1982; 306: 364–365.PubMedGoogle Scholar
  74. 74.
    Martell EA. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 309–310.CrossRefGoogle Scholar
  75. 75.
    Cohen JI. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 310.Google Scholar
  76. 76.
    Cohen BS, Harley NH. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 309–310.CrossRefGoogle Scholar
  77. 77.
    Hill CR. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 311.Google Scholar
  78. 78.
    Wagner WL. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 311.Google Scholar
  79. 79.
    Ravenholt RT. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 312.Google Scholar
  80. 80.
    Hoffman D. Wynder EL. Radioactivity in cigarette smoke. N Engl J Med 1982; 307: 312.CrossRefGoogle Scholar
  81. 81.
    Gottlieb LS, Husen LA. Lung cancer among Navajo uranium miners. Chest 1982; 81: 449–452.PubMedCrossRefGoogle Scholar
  82. 82.
    Samet JM, Kutvirt DM, Waxweiler RJ, Key CR. Uranium mining and lung cancer in Navajo men. N Engl J Med 1984; 310: 1481–1484.PubMedCrossRefGoogle Scholar
  83. 83.
    Radford EP, St. Clair Renard KG. Lung cancer in Swedish iron miners exposed to low doses of radon daughters. N Engl J Med 1984; 310: 1485–1494.PubMedCrossRefGoogle Scholar
  84. 84.
    Radford EP. Radon daughters in the induction of lung cancer in underground miners. In: Peto R, Schneiderman M, eds. Quantification of occupational cancer. Cold Spring Harbor, New York: Cold Spring Laboratory, 1981: 151–163.Google Scholar
  85. 85.
    Thomas DC, McNeill KG. Risk estimates for the health effects of alpha radiation. Ottawa: Report to the Canadian Atomic Energy Control Board, 1982.Google Scholar
  86. 86.
    The Seattle Times, Sunday, Sept 8, 1985.Google Scholar
  87. 87.
    Indoor air pollution. If you think your home is a bastion of clean air in a polluted world, think again. Consumer Reports 1985; 50: 600–603.Google Scholar
  88. 88.
    Committee on the Biological Effects of Ionizing Radiation, National Research Council. Health risks of radon and other internally deposited alpha emitters. BEIR IV. Washington, DC: National Academy Press, 1988.Google Scholar
  89. 89.
    U.S. Environmental Protection Agency. A citizen’s guide to radon: What it is and what to do about it. Washington, DC: Govt Printing Office, 1986.Google Scholar
  90. 90.
    Samet JM, Nero AV. Sounding board: Indoor radon and lung cancer. N Engl J Med 1989; 320: 591–593.Google Scholar
  91. 91.
    Vena JE, Byers TE, Cookfair D, Swanson M. Occupation and lung cancer risk. An analysis by histologic subtypes. Cancer (Philadelphia) 1985; 56: 910–917.CrossRefGoogle Scholar
  92. 92.
    Saracci R. Asbestos and lung cancer: An analysis of the epidemiological evidence on the asbestos-smoking interaction. Int J Cancer 1977; 20: 323–331.CrossRefGoogle Scholar
  93. 93.
    Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987; 9: 175–193.PubMedGoogle Scholar
  94. 94.
    Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 1979; 330: 473–490.PubMedCrossRefGoogle Scholar
  95. 95.
    Selikoff IJ, Hammond EC, Churg J. Asbestos exposure, smoking and neoplasia. JAMA 1968; 204: 106–112.PubMedCrossRefGoogle Scholar
  96. 96.
    Selikoff IJ. Asbestos and smoking. JAMA 1979; 242: 458–459.PubMedCrossRefGoogle Scholar
  97. 97.
    Sluis-Cremer GK. The relationship between asbestosis and bronchial cancer. Chest 1980; 78 (Suppl.): 380–381.PubMedGoogle Scholar
  98. 98.
    Browne K. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 1986; 43: 145–149.PubMedGoogle Scholar
  99. 99.
    Warnock ML, Churg AM. Association of asbestos and bronchogenic carcinoma in a population with low asbestos exposure. Cancer (Philadelphia) 1975; 35: 1236–1242.CrossRefGoogle Scholar
  100. 100.
    Warnock ML, Kuwahara TJ, Wolery G. The relation of asbestos burden to asbestosis and lung cancer. Pathol Annu 1983; 18 (Part 2): 109–145.PubMedGoogle Scholar
  101. 101.
    Warnock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89: 20–26.PubMedCrossRefGoogle Scholar
  102. 102.
    Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974; 29: 252–269.PubMedCrossRefGoogle Scholar
  103. 103.
    Browne K. A threshold for asbestos-related lung cancer. Br J Ind Med 1986; 43: 556–558.PubMedGoogle Scholar
  104. 104.
    McFadden D, Wright JL, Wiggs B, Churg A. Smoking inhibits asbestos clearance. Am Rev Respir Dis 1986; 133: 372–374.PubMedGoogle Scholar
  105. 105.
    McFadden D, Wright J. Wiggs B, Churg A. Cigarette smoke increases the penetration of asbestos fibers into airway walls. Am J Pathol 1986; 123: 95–99.PubMedGoogle Scholar
  106. 106.
    Barton RTH, Hogetveit ACH. Nickel-related cancers of the respiratory tract Cancer (Philadelphia) 1980; 45: 3061–3064.CrossRefGoogle Scholar
  107. 107.
    Wicks MH, Archer VE, Auerbach O, Kuschner M. Arsenic exposure in a copper smelter as related to histological type of lung cancer. Am J Ind Med 1981; 2: 25–31.PubMedCrossRefGoogle Scholar
  108. 108.
    Smith AB, Zuzuki Y. Histopathologic classification of bronchogenic carcinomas among a cohort of workers occupationally exposed to beryllium. Environ Res 1980; 21: 10–14.PubMedCrossRefGoogle Scholar
  109. 109.
    Osburn HS. Lung cancer in a mining district in Rhodesia. S Afr Med J 1969; 43: 1307–1312.PubMedGoogle Scholar
  110. 110.
    National Academy of Sciences. Committee on biologic effects of atmospheric pollutants. Chromium. Washington DC: Division of Medical Sciences. National Research Council, 1974: 58.Google Scholar
  111. 111.
    Figueroa WG, Raszkowki R, Weiss W. Lung cancer in chloromethyl methyl ether workers. N Engl J Med 1973; 288: 1096–1097.PubMedCrossRefGoogle Scholar
  112. 112.
    Wasweiler RJ, Smith AH, Falk H, Tyroler HA. Excess lung cancer risk in a synthetic chemicals plant. Environ Health Perspect 1981; 41: 159–165.CrossRefGoogle Scholar
  113. 113.
    Aksoy M. Different types of malignancies due to occupational exposure to benzene: A review of recent observations in Turkey. Environ Res 1980; 23: 181–190.Google Scholar
  114. 114.
    Yamada A. On the late injuries following occupational inhalation of the mustard gas with special references to carcinoma of the respiratory tract. Acta Pathol Jpn 1963; 13: 131–155.PubMedGoogle Scholar
  115. 115.
    Aksoy M. Hematotoxicity and carcinogenicity of benzene. Environ Health Perspect 1989; 82: 193–197.PubMedCrossRefGoogle Scholar
  116. 116.
    Yin SN, Li GL, Tain FD, et al. A retrospective cohort study of leukemia and other cancers in benzene workers. Environ Health Perspect 1989; 82: 207–213.PubMedCrossRefGoogle Scholar
  117. 117.
    Maltoni C, Ciiberti A, Cotti G, Conti B, Belpoggi F. Benzene, an experiment multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ Health Perspect 1989; 82: 109–124.PubMedCrossRefGoogle Scholar
  118. 118.
    Dubrow R, Wegman D. Setting priorities for occupational cancer research and control: Synthesis of the results of occupational disease surveillance studies. J Natl Cancer Inst 1983; 71: 1123–1142.PubMedGoogle Scholar
  119. 119.
    Morabia A, Markowitz S, Garibaldi K. Wynder EL. Lung cancer and occupation: Results of a multicentre case-control study. Br J Ind Med 1992; 49: 721–727.PubMedGoogle Scholar
  120. 120.
    Burns PB, Swanson GM. The occupational cancer incidence surveillance sutdy (OCISS): Risk of lung cancer by usual occupation and industry in the Detroit metropolitan area. Am J Ind Med 1991; 19: 655–671.PubMedCrossRefGoogle Scholar
  121. 121.
    Guberan E, Usel M, Raymond L, Bolay J, Fioretta G, Puissant J. Increased risk for lung cancer and for cancer of the gastrointestinal tract among Geneva professional drivers. Br J Ind Med 1992; 49: 337–344.PubMedGoogle Scholar
  122. 122.
    Yousem SA, Ohori P, Sonmez-Alpan E. Occurrence of human papilloma virus DNA in primary lung neoplasms. Cancer (Philadelphia) 1992; 69: 693–697.CrossRefGoogle Scholar
  123. 123.
    Kaplan MH, Susan M, Pahwa SG, et al. Neoplastic complications of HTLV-III infection: Lymphomas and solid tumors. Am J Med 1987; 82: 389–396.PubMedCrossRefGoogle Scholar
  124. 124.
    Monfardini S, Vaccher E, Pizzacaro G, et al. Unusual malignant tumors in 49 patients with HIV infection. AIDS 1989; 3: 449–452.PubMedCrossRefGoogle Scholar
  125. 125.
    Braun MA, Killan DA, Remick SC, Ruckdeschel JC. Lung cancer in HIV seropositive patients. Radiology 1990: 175: 341–343.PubMedGoogle Scholar
  126. 126.
    Remick SC, Harper GR, Abdullah MA, McSharry JJ, Ross JS, Ruckdeschel JC. Metastatic breast cancer in a young seropositive patient. J Natl Cancer Inst 1991; 83: 447–448.PubMedCrossRefGoogle Scholar
  127. 127.
    Sridhar KS, Flores MR, Raub WA, Jr., Saldana M. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 1992; 102: 1704–1708.PubMedCrossRefGoogle Scholar
  128. 128.
    Remick SC. Lung cancer: An HIV-related neoplasm or a coincidental finding? Chest 1992; 106: 1643–1644.CrossRefGoogle Scholar
  129. 129.
    Markman M, Braine HG, Abeloff MD. Histocompatibility antigens in small cell carcinoma of the lung. Cancer (Philadelphia) 1984; 54: 2943–2945.CrossRefGoogle Scholar
  130. 130.
    Whang-Peng J, Kao-Shan CS, Bunn PA, Carney DN, Gazdar AF, Minna JD. Specific chromosome defect association with human small-cell lung cancer: Deletion 3p(14–23). Science 1982; 215: 181–182.PubMedCrossRefGoogle Scholar
  131. 131.
    Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963; 30: 289–312.PubMedGoogle Scholar
  132. 132.
    Ooi WL, Elston Rch Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986; 76: 217–222.PubMedGoogle Scholar
  133. 133.
    Sellers TA, Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for non-lung cancer among relatives of lung cancer patients. Am J Epidemiol 1987; 126: 237–246.PubMedCrossRefGoogle Scholar
  134. 134.
    Lynch HT, Kimberling WJ, Markvicka SE, et al. Genetics and smoking-associated cancers. Cancer (Philadelphia) 1986: 57: 1640–1644.CrossRefGoogle Scholar
  135. 135.
    Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1986; 134: 466–470.PubMedGoogle Scholar
  136. 136.
    McDuffie HH. Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 1991; 44: 69–76.PubMedCrossRefGoogle Scholar
  137. 137.
    Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 1991; 44: 429–437.PubMedCrossRefGoogle Scholar
  138. 138.
    Sellers TA, Elston RC, Atwood LD, Rothschild H. Lung cancer histologic type and family history of cancer. Cancer (Philadelphia) 1992; 69: 86–91.CrossRefGoogle Scholar
  139. 139.
    Peto R, Doll R, Buckley JD, et al. Can dietary beta-carotene materially reduce human cancer rates? Nature (London) 1981; 290: 201–208.CrossRefGoogle Scholar
  140. 140.
    Goodman GE, Omenn GS, Feigel P, et al. Chemoprevention of lung cancer with retinol/beta-carotene. In: Meyskens FL, Prasad KN, eds. Vitamins and cancer: Human cancer prevention by vitamins and micronutrients. Clifton, NJ: Humana Press, 1985: 341–350.Google Scholar
  141. 141.
    Menkes MS, Comstock GW, Vuillenmier JP, et al. Serum beta carotene, vitamins A and E, selenium, and risk of lung cancer. N Engl J Med 1986; 315: 1250–1254.PubMedCrossRefGoogle Scholar
  142. 142.
    Ziegler RG, Mason TJ, Stemhagen A, et al. Carotenoid intake, vegetables, and the risk of lung cancer among white men in New Jersey. Am J Epidemiol 1986; 123: 1080.PubMedGoogle Scholar
  143. 143.
    Mathews-Roth MM. Carotenoids and cancer prevention-experimental and epidemiologic studies. Pure Appl Chem 1985; 57: 717–722.CrossRefGoogle Scholar
  144. 144.
    Kroes R, Beems RB, Bosland MC, et al. Nutritional factors in lung, colon, and prostate carcinogenesis in animal models. Fed Proc 1986; 45: 136–1451.PubMedGoogle Scholar
  145. 145.
    Stich H, Rosin M, Vallejera M. Reduction with vitamin A and beta-carotene administration of proportion of micronucleate buccal mucosal cells in Asian betel nut and tobacco chewers. Lancet 1984;i:1204–1206.Google Scholar
  146. 146.
    Bertram JS, Pung A, Churley M, Kappock TJ, Wilkins LR, Cooney RY. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 1991; 12: 671–678.PubMedCrossRefGoogle Scholar
  147. 147.
    Sestili MA. Chemoprevention clinical trials: Problems and Solutions. Publ. 85–2715. Bethesda: National Institutes of Health, 1984.Google Scholar
  148. 148.
    Weiss W, Seidman H, Boucot K. The Philadelphia pulmonary neoplasm research project: thwarting factors in periodic screening for lung cancer. Am Rev. Respir Dis 1975; 111: 289–297.PubMedGoogle Scholar
  149. 149.
    Nash FA, Morgan JM, Tomkins JG. South London cancer study. Br Med J 1968; 2: 715–721.PubMedCrossRefGoogle Scholar
  150. 150.
    ACS report on the cancer-related checkup: cancer of the lung; Appendix B: Experimental biases. CA Bull Cancer Prog 1980;30:199–207.Google Scholar
  151. 151.
    Brett GZ. Earlier diagnosis and survival in lung cancer. Br Med J 1969; 4: 260–262.PubMedCrossRefGoogle Scholar
  152. 152.
    Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984; 130: 549–554.PubMedGoogle Scholar
  153. 153.
    Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984; 130: 555–560.PubMedGoogle Scholar
  154. 154.
    Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: Results of the initial (prevlance) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984; 130: 561–565.PubMedGoogle Scholar
  155. 155.
    Bailar JC, Screening for lung cancer-where are we now? Am Rev Respir Dis 1984; 130: 541–542.PubMedGoogle Scholar
  156. 156.
    Weiss W. Screening for lung cancer. Chest 1985; 87: 273–274.PubMedCrossRefGoogle Scholar
  157. 157.
    Merz B. Is screening for early lung cancer worthwhile? JAMA 1983; 249: 1537–1538.PubMedCrossRefGoogle Scholar
  158. 158.
    Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer: A critique of the Mayo Lung Project. Cancer (Philadelphia) 1991; 67: 1155–1164.CrossRefGoogle Scholar
  159. 159.
    Dreis DF. Screening for lung cancer: Do chest x-rays save lives or waste money? Bull Mason Clin 1985; 39: 113–121.Google Scholar
  160. 160.
    Feld R, Rubinstein LV, Weisenberger TH, and the Lung Cancer Study Group. Sites of recurrence in resected stage 1 non-small cell lung cancer: A guide for future studies. J Clin Oncol 1984; 2: 1352–1358.Google Scholar
  161. 161.
    Li W, Hammar SP, Jolly PC, Hill LD, Anderson RP. Unpredictable course of small cell undifferentiated lung carcinoma. J Thorac Cardiovasc Surg 1981; 81: 34–43.PubMedGoogle Scholar
  162. 162.
    Carr DT, Mountain CF. Staging of lung cancer. Semin Respir Med 1982; 3: 154–163.CrossRefGoogle Scholar
  163. 163.
    Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastatis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76: 832–839.PubMedGoogle Scholar
  164. 164.
    Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (Suppl): 225S - 2335.PubMedGoogle Scholar
  165. 165.
    Mountain CF, Greenberg SD, Fraire AE. Tumor stage in non-small cell carcinoma of the lung. Chest 1991; 99: 1258–1260.PubMedCrossRefGoogle Scholar
  166. 166.
    Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by post-surgical pathologic staging. Cancer (Philadelphia) 1990; 65: 2503–2506.CrossRefGoogle Scholar
  167. 167.
    Bulzebruck H, Bopp R, Drings P, et al. New aspects in the staging of lung cancer: Prospective validation on the international union against cancer TNM classification. Cancer (Philadelphia) 1992; 70: 1102–1110.CrossRefGoogle Scholar
  168. 168.
    Tisi GM, Friedman PJ, Peters RM, et al. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983; 127: 659–664.Google Scholar
  169. 169.
    Decker DA, Dines DE, Payne WS, et al. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest 1978; 74: 640–642.PubMedCrossRefGoogle Scholar
  170. 170.
    Grillo HC. Carinal reconstruction. Ann Thorac Surg 1982; 34: 356–373.PubMedCrossRefGoogle Scholar
  171. 171.
    Sartori F. Right upper tracheal sleeve lobectomy for carcinoma of the lung. Reconstruction of tracheal bifurcation. Minerva Chir 1984; 39: 209–212.PubMedGoogle Scholar
  172. 172.
    Gilbert A, Deslauriers J, McLish A, Piraux M. Tracheal sleeve pneumonectomy for carcinoma of the proximal left main bronchus. Can J Surg 1984; 27: 583–585.PubMedGoogle Scholar
  173. 173.
    The World Health Organization histological typing of lung tumors. 2d Ed. Am J Clin Pathol 1982;77:123–136.Google Scholar
  174. 174.
    Watkin SW. Temporal demographic and epidemiologic variation in histologic subtypes of lung cancer: A literature review. Lung Cancer 1989; 5: 69–81.CrossRefGoogle Scholar
  175. 175.
    Kung ITM, So KF, Lum TH. Lung cancer in Hong Kong Chinese: Mortality and histologic types 19731982. Br J Cancer 1984; 50: 381–388.PubMedCrossRefGoogle Scholar
  176. 176.
    Whitwell F. The histopathology of lung cancer in Liverpool: The specificity of the histological cell types of lung cancer. Br J Cancer 1961; 15: 440–459.PubMedCrossRefGoogle Scholar
  177. 177.
    Feinstein AR, Gelfman NA, Yesner R. Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis 1970; 101: 671–684.PubMedGoogle Scholar
  178. 178.
    Stanley KE, Matthews MJ. Analysis of a pathology review of patients with lung tumours. J Natl Cancer Inst 1981; 66: 989–992.PubMedGoogle Scholar
  179. 179.
    Vincent RG, Pickren JW, Lane WW, et al. The changing histopathology of lung cancer: A review of 1682 cases. Cancer (Philadelphia) 1977; 39: 1647–1565.CrossRefGoogle Scholar
  180. 180.
    Larsson S. Completeness and reliability of lung cancer registration in the Swedish Cancer Registry. Acta Pathol Microbiol Scand A Pathol 1.971; 79: 389–398.Google Scholar
  181. 181.
    El-Torky M, El-Zeky F, Hall JC. Significant changes in the distribution of histologic types of lung cancer: A review of 4928 cases. Cancer (Philadelphia) 1990; 65: 2361–2367.CrossRefGoogle Scholar
  182. 182.
    Auerbach O, Garfinkel L. The changing pattern of lung carcinoma. Cancer (Philadelphia) 1991; 68: 1973–1977.CrossRefGoogle Scholar
  183. 183.
    Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer (Philadelphia) 1991; 68: 2074–2078.CrossRefGoogle Scholar
  184. 184.
    Yesner R. Spectrum of lung cancer and ectopic hormones. Pathol Annu 1978; 13 (Part 1): 217–240.Google Scholar
  185. 185.
    Adelstein DJ, Tomahefski JF, Snow NJ, Horrigan JP, Hines JD. Mixed small cell and non-small cell lung cancer. Chest 1986; 89: 699–704.PubMedCrossRefGoogle Scholar
  186. 186.
    Roggli VL, Volmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R. Lung cancer heterogeneity: A blinded and randomized study of 100 consecutive cases. Hum Pathol 1985; 16: 569–579.PubMedCrossRefGoogle Scholar
  187. 187.
    Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70: 606–612.PubMedGoogle Scholar
  188. 188.
    Razzuk MA, Pockey M. Urschel HC, Paulson DL. Dual primary bronchogenic carcinoma. Ann Thorac Surg 1974; 17: 425–433.PubMedCrossRefGoogle Scholar
  189. 189.
    Rohwedder JJ, Weatherbee L. Multiple primary bronchogenic carcinoma. Ann Thorac Surg 1974; 17: 425–433.CrossRefGoogle Scholar
  190. 190.
    Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer (Philadelphia) 1932; 16: 1358–1414.Google Scholar
  191. 191.
    Auerbach O, Stout AP, Hammond EC, Garfinkel L. Multiple primary bronchial carcinomas. Cancer (Philadelphia) 1967; 20: 699–705.CrossRefGoogle Scholar
  192. 192.
    Struve-Christensen E. Diagnosis and treatment of bilateral primary bronchogenic carcinoma. J Thorac Cardiovasc Surg 1971; 61: 501–513.PubMedGoogle Scholar
  193. 193.
    Jung-Legg Y, McGowan SF, Sweeney KG, Zitzman JL, Pugntch RP. Synchronous triple malignant tumors of the lung: A case report of bronchial carcinoid, small cell carcinoma, and adenocarcinoma of the right lung. Am J Clin Pathol 1986; 85: 96–101.PubMedGoogle Scholar
  194. 194.
    Wu S, Lin Z, Xu C, Koo K, Huang O, Xie D. Multiple primary lung cancers. Chest 1987; 92: 892–896.PubMedCrossRefGoogle Scholar
  195. 195.
    Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers: results of surgical treatment. J Thorac Cardiovasc Surg 1990; 99: 769–778.PubMedGoogle Scholar
  196. 196.
    Seydel HG, Chait A, Gmelich JT. The natural history of cancer of the lung. In: Seydel HG, Chait A, Gmelich JT, eds. Cancer of the lung. New York: Wiley, 1975: 52–63.Google Scholar
  197. 197.
    Auerbach O. Natural history of carcinoma of the lung. In: Fishman AP, ed. Pulmonary diseases and disorders. New York: McGraw-Hill, 1980; 1388–1396.Google Scholar
  198. 198.
    Miller YE. Growth factors, oncogenes and lung cancer. Am Rev Respir Dis 1985; 132: 178–179.PubMedGoogle Scholar
  199. 199.
    Wick MR. Oncogene analysis in diagnostic pathology: A current perspective. Am J Clin Pathol 1992; 97 (Supp1.1): S1 - S3.PubMedGoogle Scholar
  200. 200.
    Viallet J, Minna JD. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. Am J Respir Cell Mol Biol 1990; 2: 225–232.PubMedCrossRefGoogle Scholar
  201. 201.
    Damstrup L, Rorth M, Poulsen HS. Growth factors and growth factor receptors in human malignancies with special reference to lung cancer: a review. Lung Cancer 1989; 5: 49–68.CrossRefGoogle Scholar
  202. 202.
    Paul J. Oncogenesis. In: Anthony PP, MacSween RN M, eds. Recent advances in histopathology. London: Churchill-Livingstone, 1987: 13–31.Google Scholar
  203. 203.
    Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 1956; 76: 988–1000.PubMedGoogle Scholar
  204. 204.
    Geddes DM. The natural history of lung cancer: A review based on rates of tumour growth. Br J Dis Chest 1979; 73: 1–17.PubMedCrossRefGoogle Scholar
  205. 204a.
    Brenner MW, Holsti LR, Pertolla Y. The study of graphical analysis of the growth of human tumours and metastases of the lung Br J Cancer 1967; 1–13.Google Scholar
  206. 204b.
    Breuer K. Growth rate and radiosensitivity of human tumours. Europ J Cancer 1966; 2: 157–171.Google Scholar
  207. 204c.
    Chahinian P. Relationship between tumour doubling time and anatomoclinical features in 50 measurable pulmonary cancers. Chest 1972; 61: 340–345.PubMedCrossRefGoogle Scholar
  208. 204d.
    Garland LH, Coulson W, Wollin E. The rate of growth and apparent duration of untreated primary bronchial carcinoma. Cancer, N.Y., 1963; 16: 694–707.PubMedGoogle Scholar
  209. 204e.
    Garland LH. The rate of growth and apparent duration of primary bronchial cancer. Am J Roent Rad Ther 1966; 96: 604–611.CrossRefGoogle Scholar
  210. 204f.
    Meyer JA. Growth rate versus prognosis in resected primary bronchogenic cancer. Cancer, N.Y., 1973; 31: 1468–1472.PubMedGoogle Scholar
  211. 204g.
    Schwartz M. A biomathematical approach to clinical tumour growth. Cancer, N.Y., 1961; 14: 1272–1294.PubMedGoogle Scholar
  212. 204h.
    Steele JD, Buell P. A symptomatic solitary pulmonary nodules. J Thorac Cardiovasc Surg 1973; 65: 140–151.PubMedGoogle Scholar
  213. 204i.
    Weiss W, Boucot KR, Cooper DA. Growth rate in the detection and prognosis of bronchogenic carcinoma. JAMA 1966; 198: 1246–1256.PubMedCrossRefGoogle Scholar
  214. 204j.
    Weiss W. Tumour doubling time and survival of men with bronchogenic carcinoma. Chest 1974; 65: 3–8.PubMedCrossRefGoogle Scholar
  215. 205.
    Chahinian P, Israel L. Rates and patterns of growth of lung cancer. In: Israel L, Chahinian P, eds. Lung cancer: Natural history, prognosis and therapy. New York: Academic Press, 1976: 63–79.Google Scholar
  216. 206.
    Chahinian P, Israel L. Prognostic value of doubling times and related factors in lung cancer. In: Israel L, Chahinian P, eds, Lung cancer: Natural history, prognosis and therapy. New York: Academic Press, 1976: 95–106.Google Scholar
  217. 207.
    Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rates. Radiology 1962; 79: 221–231.PubMedGoogle Scholar
  218. 208.
    Kerr KM, Lamb D. Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. Br J Cancer 1984; 50: 343–349.PubMedCrossRefGoogle Scholar
  219. 209.
    Greengard O, Head JF, Goldberg SL, Kirschner PA. Biochemical measure of the volume doubling time of human pulmonary neoplasms. Cancer (Philadelphia) 1985; 55: 1530–1535.CrossRefGoogle Scholar
  220. 210.
    Byrd RB, Miller WE, Carr DT. The roentgenographic appearance of squamous cell carcinoma of the bronchus. Mayo Clin Proc 1968; 43: 327–332.PubMedGoogle Scholar
  221. 211.
    Walter JB, Pryce DM. The site of origin of lung cancer and its relation to histological type. Thorax 1955; 10: 117–126.PubMedCrossRefGoogle Scholar
  222. 212.
    Chaudhuri MR. Primary pulmonary cavitating carcinomas. Thorax 1973; 28: 354–366.PubMedCrossRefGoogle Scholar
  223. 213.
    Dulmet-Brender E. Jaubert F, Huchon G. Exophytic endobronchial epidermoid carcinoma. Cancer (Philadelphia 1986; 57: 1358–1364.CrossRefGoogle Scholar
  224. 214.
    Carter D, Eggleston JC. Squamous cell carcinoma. In: Tumors of the lower respiratory tract (Atlas of tumor pathology, 2d Ser., Fasc. 17 ). Washington DC: Armed Forces Institute of Pathology 1980; 70–94.Google Scholar
  225. 215.
    Trump BF, McDowell EM, Glavin F, et al. The respiratory epithelium. III. Histogenesis of epidermoid metaplasia and carcinoma in situ in the human. J Natl Cancer Inst 1978; 61: 563–575.PubMedGoogle Scholar
  226. 216.
    Yamamoto M, Shimokata K, Nagura H. Immunoelectron microscopic study on the histogenesis of epidermoid metaplasia in respiratory epithelium. Am Rev Respir Dis 1987; 135: 713–718.PubMedGoogle Scholar
  227. 217.
    Valaitis J, Warren S, Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer (Philadelphia) 1981; 47: 1042–1046.CrossRefGoogle Scholar
  228. 218.
    Taylor AB, Shinton NH, Waterhouse JAH. Histology of bronchial carcinoma in relation to prognosis. Thorax 1963; 18: 178–181.PubMedCrossRefGoogle Scholar
  229. 219.
    Weiss W, Boucot KR, Cooper DA. The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer (Philadelphia) 1970; 26: 965–970.CrossRefGoogle Scholar
  230. 220.
    Ashley DJB, Davies HD. Cancer of the lung: Histology and biological behaviour. Cancer (Philadelphia) 1967; 20: 165–174.CrossRefGoogle Scholar
  231. 221.
    Bennett DE, Sasser WR, Ferguson TB. Adenocarcinoma of the lung in men: A clinicopathologic study of 100 cases. Cancer (Philadelphia) 1969; 23: 431–439.CrossRefGoogle Scholar
  232. 222.
    Raeburn C, Spencer H. A study of the origin and development of lung cancer. Thorax 1953; 8: 1–10.PubMedCrossRefGoogle Scholar
  233. 223.
    Raeburn C, Spencer H. Lung scar cancers. Br J Tuberc Dis Chest 1957; 51: 237–245.PubMedCrossRefGoogle Scholar
  234. 224.
    Carroll R. Influence of lung scars on primary lung cancer. J Pathol Bacteriol 1962; 83: 293–297.PubMedCrossRefGoogle Scholar
  235. 225.
    Auerbach O, Garfinkel L, Parks VR. Scar cancer of the lung: Increase over a 21-year period. Cancer (Philadelphia) 1979; 43: 636–642.CrossRefGoogle Scholar
  236. 226.
    Scannell JG. “Bleb” carcinoma of the lung. J Thorac Cardiovasc Surg 1980;80:904–908.Google Scholar
  237. 227.
    Konwaler BE, Reingold IM. Carcinoma arising in bronchiectatic cavities. Cancer (Philadelphia) 1952; 5: 525–529.CrossRefGoogle Scholar
  238. 228.
    Shimosato Y, Hashimoto T, Kodama T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 1980; 4: 365–373.PubMedCrossRefGoogle Scholar
  239. 229.
    Madri JA, Carter D. Scar cancers of the lung: Origin and significance. Hum Pathol 1984; 15: 625–631.PubMedCrossRefGoogle Scholar
  240. 230.
    Kung ITM, Lui IOL, Loke SL, et al. Pulmonary scar cancer: A pathologic reappraisal. Am J Surg Pathol 1985; 9: 391–400.PubMedCrossRefGoogle Scholar
  241. 231.
    Cagle PT, Cohle SD, Greenberg SD. Natural history of pulmonary scar cancers: Clinical and pathologic implications. Cancer (Philadelphia) 1985; 56: 2031–2035.CrossRefGoogle Scholar
  242. 232.
    Barsky SH, Huang SJ, Bhuta S. The extracellular matrix of pulmonary scar carcinomas is suggestive of a desmoplastic origin. Am J Pathol 1986; 124: 412–419.PubMedGoogle Scholar
  243. 233.
    Meyer EC, Liebow AA. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer (Philadelphia) 1965; 218: 322–351.CrossRefGoogle Scholar
  244. 234.
    Fox B, Ridson RA. Carcinoma of the lung and diffuse interstitial pulmonary fibrosis. J Clin Pathol 1968;21: 486–491.Google Scholar
  245. 235.
    Haddad R, Massaro D. Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med 1968; 45: 211–219.PubMedCrossRefGoogle Scholar
  246. 236.
    Fraire AE, Greenberg SD. Carcinoma and diffuse interstitial fibrosis of lung. Cancer 1973; 31: 1078–1086.PubMedCrossRefGoogle Scholar
  247. 237.
    Turner-Warwick M, Lebowitz M. Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980; 35: 496–499.PubMedCrossRefGoogle Scholar
  248. 238.
    Zatuchni J, Campbell WN, Zarafonetis CJD. Pulmonary fibrosis and terminal bronchiolar (’alveolar cell’) carcinoma in scleroderma. Cancer (Philadelphia) 1953; 6: 1147–1158.CrossRefGoogle Scholar
  249. 239.
    Collins DH, Darke CS, Dodge OG. Scleroderma with honeycomb lung and bronchiolar carcinoma. J Pathol Bacteriol 1958; 76: 531–540.PubMedCrossRefGoogle Scholar
  250. 240.
    Caplan H. Honeycomb lungs and malignant pulmonary adenomatosis in scleroderma. Thorax 1959; 14: 89–96.PubMedCrossRefGoogle Scholar
  251. 241.
    Montgomery RD, Stirling GA, Hamer NAJ. Bronchiolar carcinoma in progressive systemic sclerosis. Lancet 1962;iii:693–695.Google Scholar
  252. 242.
    Liebow AA. Bronchiolo-alveolar carcinoma. Adv Intern Med 1960; 10: 329–358.PubMedGoogle Scholar
  253. 243.
    Rosenblatt MB, Lisa JR, Collier F. Primary and metastatic bronchiolo-alveolar carcinoma. Dis Chest 1967; 52; 147–152.PubMedCrossRefGoogle Scholar
  254. 244.
    Clayton F. Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer (Philadelphia) 1986; 57: 1555–1564.CrossRefGoogle Scholar
  255. 245.
    Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988; 23: 361–394.PubMedGoogle Scholar
  256. 246.
    Adamson JS, Senior RM, Merrill T. Alveolar cell carcinoma: an electron microscopic study. Am Rev Respir Dis 1969; 100: 550–557.PubMedGoogle Scholar
  257. 247.
    Coalson JJ, Mohr JA, Pirtle JK, Dee AL, Rhoades ER. Electron microscopy of neoplasms in the lung with special emphasis on the alveolar cell carcinoma. Am Rev Respir Dis 1970; 101: 181–197.PubMedGoogle Scholar
  258. 248.
    Kuhn C. Fine structure of bronchiolo-alveolar cell carcinoma. Cancer (Philadelphia) 1972; 30: 1107–1118.CrossRefGoogle Scholar
  259. 249.
    Nash G, Langlinais PC, Greenwald KA. Alveolar cell carcinoma: Does it exist? Cancer (Philadelphia) 1972; 29: 322–326.CrossRefGoogle Scholar
  260. 250.
    Bedrossian CWM, Weilbaecher DG, Bentinck DC, Greenberg SD. Ultrastructure of human bronchiolo-alveolar cell carcinoma. Cancer (Philadelphia) 1975; 36: 1399–1413.CrossRefGoogle Scholar
  261. 251.
    Bonikos DS, Hendrickson,M, Bensch KG. Pulmonary alveolar cell carcinoma. Fine structural and in vitro. study of a case and critical review of this entity. Am J Surg Pathol 1977; 1: 93–108.PubMedCrossRefGoogle Scholar
  262. 252.
    Sidhu GS, Forrester EM. Glycogen-rich Clara cell-type bronchiolo-alveolar cell carcinoma. Light and electron microscopic study. Cancer (Philadelphia) 1977; 40: 2209–2215.CrossRefGoogle Scholar
  263. 253.
    Kimula Y. A histochemical and ultrastructural study of adenocarcinoma of the lung. Am J Surg Pathol 1978; 2: 253–264.PubMedCrossRefGoogle Scholar
  264. 254.
    Morningstar WA, Hassan MO. Bronchiolo-alveolar cell carcinoma with nodal metastases Am J Surg Pathol 1979; 3: 273–278.CrossRefGoogle Scholar
  265. 255.
    Carter D, Eggleston JC. Bronchioloalveolar carcinoma. In: Tumors of the lower respiratory tract (Atlas of tumor pathology, 2d Ser., Fasc. 17 ). Washington, DC: Armed Forces Institute of Pathology, 1980: 127–147.Google Scholar
  266. 256.
    Hammar SP, Bolen J W, Bockus D, Remington F, Friedman S. Ultrastructural and immunohistochemical features of common lung tumors: An overview. Ultrastruct Pathol 1985; 9: 283–318.Google Scholar
  267. 257.
    Clayton F. Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer (Philadelphia) 1986; 57: 1555–1564.CrossRefGoogle Scholar
  268. 258.
    Herrera GA, Alexander CB, deMoraes HP. Ultrastructural subtypes of pulmonary adenocarcinoma. Correlation with patient survival. Chest 1983; 84: 581–586.PubMedCrossRefGoogle Scholar
  269. 259.
    Dekmezian R, Ordonez NG, Mackay B. Bronchioloalveolar adenocarcinoma with myoepithelial cells. Cancer (Philadelphia) 1991; 67: 2356–2360.CrossRefGoogle Scholar
  270. 260.
    Torikata C, Ishiwata K. Intranuclear tubular structures observed in the cells of alveolar cell carcinomas of the lung. Cancer (Philadelphia) 1977; 40: 1194–1201.CrossRefGoogle Scholar
  271. 261.
    Singh G, Katyal SL, Torikata C. Carcinoma of type II pneumocytes: Immunodiagnosis of a subtype of bronchioloalveolar carcinoma. Am J Pathol 1981; 102: 195208.Google Scholar
  272. 262.
    Singh G, Katyal SL, Torikata C. Carcinoma of type II pneumocytes: PAS staining as a screening test for nuclear inclusions of surfactant-specific appoprotein. Cancer (Philadelphia) 1982; 50: 946–948.CrossRefGoogle Scholar
  273. 263.
    Ghadially FN, Harawi S, Khan W. Diagnostic ultra-structural markers in alveolar cell carcinoma. J Submicrosc Cytol 1985; 17: 269–278.PubMedGoogle Scholar
  274. 264.
    Singh G, Scheithauer BW, Katyal S. The pathobiologic features of carcinomas of type II penumocytes. Cancer (Philadelphia) 1986; 57: 994–999.CrossRefGoogle Scholar
  275. 265.
    Hammar S, Bockus D, Remington F. Metastatic tumor of unknown origin. Ultrastruct Pathol 1986; 10: 28 1288.Google Scholar
  276. 266.
    Basset F, Soler P, Wyllie L, et al. Langerhans cells in a bronchioloalveolar tumor of lung. Virchow Arch [Pathol Anat] 1974; 362: 315–330.CrossRefGoogle Scholar
  277. 267.
    Hammar SP, Bockus D, Remington F, et al. Langerhans cells and serum precipitating antibodies against fungal antigen in bronchioloalveolar cell carcinomas; possible association with eosinophilic granuloma. Ultrastruct Pathol 1980; 1: 19–37.PubMedCrossRefGoogle Scholar
  278. 268.
    Hammar SP, Bockus D, Remington F, Bartha M. The widespread distribution of Langerhans cells in pathologic tissues: An ultrastructural and immunohistochemical study. Hum Pathol 1986; 17: 894–905.PubMedCrossRefGoogle Scholar
  279. 269.
    Takakura H, Hirohashi S, Shimosato Y, et al. Immunomorphologic responses of regional lymph nodes and prognosis in patients with stage I-A peripheral bronchial adenocarcinoma. Jpn J Cancer Clin 1983; 29: 777–785.Google Scholar
  280. 270.
    Furukawa T, Watanabe S, Kodoma T, Sato Y, Shimosato Y, Suemasu K. T-zone histiocytes in adenocarcinoma of lung in relation to postoperative prognosis. Cancer (Philadelphia) 1985; 56: 2651–2656.CrossRefGoogle Scholar
  281. 271.
    Nakanishi K, Kawai T, Suzuki M. Large intracytoplasmic body in lung cancer compared with Clara cell granule. Am J Clin Pathol 1987; 88: 472–477.PubMedGoogle Scholar
  282. 272.
    Scroggs MW, Roggli VL, Fraire AE, Sanfilippo F. Eosinophilic intracytoplasmic globules in pulmonary adenocarcinomas: A histochemical, immunohistochemical and ultrastructural study of six cases. Hum Pathol 1989; 20: 845–849.PubMedCrossRefGoogle Scholar
  283. 273.
    Axiotis A, Jennings TA. Observations on bronchioloalveolar carcinomas with special emphasis on localized lesions: A clinicopathologic, ultrastructural and immunohistochemical study of 11 cases. Am J Surg Pathol 1988; 12: 918–931.PubMedCrossRefGoogle Scholar
  284. 274.
    Miller RR, Nelems B, Evans KG, Muller NL, Ostrow DN. Glandular neoplasia of the lung: A proposed analogy to colonic tumors. Cancer (Philadelphia) 1988; 61: 1009–1014.CrossRefGoogle Scholar
  285. 275.
    Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol 1990; 14: 904–912.PubMedCrossRefGoogle Scholar
  286. 276.
    Yousem SA, Hochholzer L. Alveolar adenoma. Hum Pathol 1986; 17: 1066–1071.PubMedCrossRefGoogle Scholar
  287. 277.
    Travis WD, Linnoila RI, Horowitz M, et al. Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients. Mod Pathl 1988; 5: 372–377.Google Scholar
  288. 278.
    Noguchi M, Kodama T, Shimosato Y, et al. Papillary adenoma of type II pneumocytes. Am J Surg Pathol 1986; 10: 134–139.PubMedCrossRefGoogle Scholar
  289. 279.
    Hegg CA, Flint A, Sing G. papillary adenoma of the lung. Am J Clin Pathol 1992; 97: 393–397.PubMedGoogle Scholar
  290. 280.
    Hammar S. Adenocarcinoma and large cell undifferentiated carcinoma of the lung. Ultrastruct Pathol 1987; 11: 251–274.PubMedCrossRefGoogle Scholar
  291. 281.
    Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 20: 192–202.CrossRefGoogle Scholar
  292. 282.
    Afzelius BA. Glycocalyx and glycocalyceal bodies in the respiratory epithelium of nose and bronchi. Ultrastruct Pathol 1984; 7: 1–8.PubMedCrossRefGoogle Scholar
  293. 283.
    Kish JK, Ro JY, Ayala AG, McMurtrey MJ. Primary mucinous adenocarcinoma of the lung with signet-ring cells: A histochemical comparison with signet-ring cell carcinomas of other sites. Hum Pathol 1989; 20: 1097–1102.PubMedCrossRefGoogle Scholar
  294. 284.
    Graeme-Cook F, Mark EJ. Pulmonary mucinous tumors of borderline malignancy. Hum Pathol 1991; 22: 185–190.PubMedCrossRefGoogle Scholar
  295. 285.
    Higashiyama M, Doi O, Kodama K. Yokouchi H, Tateishi R. Cystic mucinous adenocarcinomas of the lung: Two cases of cystic variant of mucus-producing lung adenocarcinoma. Chest 1992; 101: 763–766.PubMedCrossRefGoogle Scholar
  296. 286.
    Moran CA, Hochholzer L, Fishback N, Travis WD, Koss MN. M-ucinous (so-called colloid) carcinomas of lung. Mod Pathol 1992; 5: 634–638.PubMedGoogle Scholar
  297. 287.
    Tsao M, Fraser RS. Primary pulmonary adenocarcinoma with enteric differentiation. Cancer (Philadelphia) 1991; 68: 1754–1757.CrossRefGoogle Scholar
  298. 288.
    Brambilla E, Moro D, Veale D, et al. Basal cell (basaloid) carcinoma of the lung: A new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 1992; 23: 993–1003.PubMedCrossRefGoogle Scholar
  299. 289.
    Kodama T, Shimosato Y, Koide T, Watanabe S, Yoneyama T. Endobronchial polypoid adenocarcinoma of the lung: Histologic and ultrastructural studies of five cases. Am J Surg Pathol 1984; 8: 845–854.PubMedCrossRefGoogle Scholar
  300. 290.
    Cagle PT, Alpert LC, Carmona PA. Peripheral biphasic adenocarcinoma of the lung: light microscopic and immunohistochemical findings. Hum Pathol 1992; 23: 197–200.PubMedCrossRefGoogle Scholar
  301. 291.
    Upton MP, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimosato Y. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol 1986; 10: 560–567.PubMedCrossRefGoogle Scholar
  302. 292.
    Jasani B, Edwards RE, Thomas ND, Gibbs AR. The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virchows Arch [Pathol Anat] 1985; 406: 441–448.CrossRefGoogle Scholar
  303. 293.
    Cherwitz D, Swanson, P, Drier J, Wick M. S 100-protein reactivity in poorly differentiated carcinomas: An immunohistochemical comparison with malignant melanoma. Lab Invest 1987; 56: 13A.Google Scholar
  304. 294.
    Linnoila R, Jensen SM, Steinberg SM, Mulshine JL, Eggelston JC, Gazdar AF. Peripheral airway cell marker expression in non-small cell lung carcinoma. Am J Clin Pathol 1992; 97: 233–243.PubMedGoogle Scholar
  305. 295.
    Delmonte VC, Alberti O, Saldiva PHN. Large cell carcinoma of the lung: Ultrastructural and immunohistochemical features. Chest 1986; 90: 524–527.PubMedCrossRefGoogle Scholar
  306. 296.
    Churg A. The fine structure of large cell undifferentiated carcinoma of the lung: Evidence for its relation to squamous cell carcinomas and adenocarcinomas. Hum Pathol 1978; 9: 143–156.PubMedCrossRefGoogle Scholar
  307. 297.
    Horie A, Ohta M. Ultrastructural features of large cell carcinoma of the lung with reference to the prognosis in patients. Hum Pathol 1981; 12: 423–432.PubMedCrossRefGoogle Scholar
  308. 298.
    Leong AS. The relevance of ultrastructural examination in the classification of primary lung tumors. Pathology 1982; 14: 37–46.PubMedCrossRefGoogle Scholar
  309. 299.
    Albain KS, True LD, Golomb HM. Hoffman PC, Little AG. Large cell carcinoma of the lung: ultrastructural differentiation and clinicopathologic correlations. Cancer (Philadelphia) 1985; 56: 1618–1623.CrossRefGoogle Scholar
  310. 300.
    Osborne BM, Mackay B. Butler JJ, Ordonez NG. Large cell lymphoma with microvilluslike projections: an ultrastructural study. Am J Clin Pathol 1983; 79: 443–450.PubMedGoogle Scholar
  311. 301.
    Butler AE, Colby TV, Weiss L, Lombard C. Lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol 1989; 13: 632–639.PubMedCrossRefGoogle Scholar
  312. 302.
    Nash G, Stout AP. Giant cell carcinoma of the lung: report of 5 cases. Cancer (Philadelphia) 1958; 11: 369–376.CrossRefGoogle Scholar
  313. 303.
    Hellstrom HR, Fisher ER. Giant cell carcinoma of lung. Cancer (Philadelphia) 1963; 16: 1080–1088.CrossRefGoogle Scholar
  314. 304.
    Flanagan P, Roeckel IE. Giant cell carcinoma of the lung: Anatomic and clinical correlation. Am J Med 1964; 36: 214–222.PubMedCrossRefGoogle Scholar
  315. 305.
    Kallenberg F, Jaque J. Giant cell carcinoma of the lung: Clinical and pathologic assessment; comparison with other large-cell anaplastic bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg 1979; 13: 343–346.Google Scholar
  316. 306.
    Shin MS, Jackson LK, Shelton RW, Greene RE. Giant cell carcinoma of the lung: Clinical and roentgenographic manifestations. Chest 1986; 89: 366–369.PubMedCrossRefGoogle Scholar
  317. 307.
    Ozzello L, Stout AP. The epithelial origin of giant cell carcinoma of the lung confirmed by tissue culture; report of a case. Cancer (Philadelphia) 1961; 14: 1052–1056.CrossRefGoogle Scholar
  318. 308.
    Wang NS, Seemayer TA, Ahmed MN, Knaack J. Giant cell carcinoma of the lung: A light and electron microscopic study. Hum Pathol 1976; 7: 3–16.Google Scholar
  319. 309.
    Ginsberg SS, Buzaid AC, Stern H, Carter D. Giant cell carcinoma of the lung. Cancer (Philadelphia) 1992; 70: 606–610.CrossRefGoogle Scholar
  320. 310.
    Yesner R, Gerstl B, Auerbach O. Application of World Health Organization classification of lung carcinoma to biopsy material. Ann Thorac Surg 1965; 1: 33–49.CrossRefGoogle Scholar
  321. 311.
    Kern WH, Jones JC, Chapman ND. Pathology of bronchogenic carcinoma in long-term survivors. Cancer (Philadelphia) 1968; 21: 772–780.CrossRefGoogle Scholar
  322. 312.
    Auerbach O, Frasca JM, Parks VR, et al. A comparison of World Health Organization (WHO) classification of lung tumors by light and electron microscopy. Cancer (Philadelphia) 1982; 50: 2079–2088.CrossRefGoogle Scholar
  323. 313.
    Ashley DJ, Davies HD. Mixed glandular and squamous-cell carcinoma of the bronchus. Thorax 1967; 22: 431–436.PubMedCrossRefGoogle Scholar
  324. 314.
    Fitzgibbons PL, Kern WH. Adenosquamous carcinoma of the lung: A clinical and pathologic study of seven cases. Hum Pathol 1985; 16: 463–466.PubMedCrossRefGoogle Scholar
  325. 315.
    McDowell EM, McLaughlin JS, Merenyl DK, et al. The respiratory epithelium. V. Histogenesis of lung carcindomas in the human. J Natl Cancer Inst 1978; 61: 587–606.PubMedGoogle Scholar
  326. 316.
    Wilson TS, McDowell EM, Trump BF. Immunohistochemical studies of keratinization in human lung tumors. J Cell Biol 1981; 91: 299a.Google Scholar
  327. 317.
    Takamori S, Noguchi M, Morinaga S, Goya T, Tsugane S, Kakegawa T, Shimosato Y. Clinicopathologic characteristics of adenosquamous carcinoma of the lung. Cancer (Philadelphia) 1991; 67: 649–654.CrossRefGoogle Scholar
  328. 318.
    Ishida T, Kaneko S, Yokoyama H, Inoue T, Sugio K, Sugimachi K. Adenosquamous carcinoma of the lung: Clinicopathologic and immunohistochemical features. Am J Clin Pathol 1992; 97: 678–685.PubMedGoogle Scholar
  329. 319.
    Yousem SA. Pulmonary adenosquamous carcinomas with amyloid-like stroma. Mod Pathol 1989; 2: 420–426.PubMedGoogle Scholar
  330. 320.
    Feyrter F. Ueber diffuse endokrine epitheliate organe. Zentralbl Inn Med 1938; 59: 545–561.Google Scholar
  331. 321.
    Pearse AGE. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of this concept. J Histochem Cytochem 1969; 17: 303–313.PubMedCrossRefGoogle Scholar
  332. 322.
    Pearse AGE, Takor Takor T. Embyrology of the diffuse neuroendocrine system and its relationship to the common peptides. Fed Proc 1979; 38: 2288–2294.PubMedGoogle Scholar
  333. 323.
    Pearse AGE. The diffuse neuroendocrine system: an extension of the APUD concept. In: Taylor S, ed. Endocrinology. London: Heinemann, 1972: 145.Google Scholar
  334. 324.
    Gould VE, DeLellis RA. The neuroendocrine cell system: its tumors, hyperplasias, and dysplasias. In: Silverberg SG, ed. Principles and practice of surgical pathology. New York: Wiley, 1983: 1488–1501.Google Scholar
  335. 325.
    Gould VE, Moll R, Moll I, Lee I, Franke WW. Neuroendocrine (Merkel) cells of the skin: hyperplasias dysplasias and neoplasms. Lab Invest 1985; 52: 334–353.PubMedGoogle Scholar
  336. 326.
    Gould VE, Linnoila RI, Memoli VA, Warren WH. Neuroendocrine components of the bronchopulmonary tract: Hyperplasias, dysplasias, and neoplasms. Lab Invest 1983; 49: 519–537.PubMedGoogle Scholar
  337. 327.
    Gould VE, Wiedenmann B, Lee I, et al. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Am J Pathol 1987; 126: 243–257.PubMedGoogle Scholar
  338. 328.
    Hammar S, Gould VE. Neuroendocrine neoplasms. In: Azar HA, ed. Pathology of human neoplasms: an atlas of diagnostic electron microscopy and immunohistochemistry. New York: Raven Press, 1988: 333–404.Google Scholar
  339. 329.
    Barnes PJ, Baranivk JN, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144(1):1187–1198; (2):1391–1399.Google Scholar
  340. 330.
    Haimoto H, Takahashi Y, Koshikawa T, Nagura H, Kato K. Immunohistochemical localization of y-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985; 52: 257–263.PubMedGoogle Scholar
  341. 331.
    Pahlman S, Esscher T, Nilsson K. Expression of ‘y-subunit of enolase, neuron-specific enolase in human nonneuroendocrine tumors and derived cell lines. Lab Invest 1986; 54: 554–560.PubMedGoogle Scholar
  342. 332.
    Vinores SA, Bonnin JM, Rubinstein LJ, Marangos PJ. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med 1984; 120: 186–192.Google Scholar
  343. 333.
    Bergh J, Escher T, Steinholtz L, Nilsson K, Pahlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol 1985; 84: 1–7.PubMedGoogle Scholar
  344. 334.
    Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 1985; 16: 236–240.PubMedCrossRefGoogle Scholar
  345. 335.
    Schmechel DE. y-subunit of the glycolytic enzyme enolase: nonspecific or neuron specific? Lab Invest 1985; 52:239–242.Google Scholar
  346. 336.
    O’Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab 1983; 57: 1084–1086.PubMedCrossRefGoogle Scholar
  347. 337.
    Lloyd RV, Wilson BS, Kovacs K, Ryan N. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas. Arch Pathol Lab Med 1985; 109: 515–517.PubMedGoogle Scholar
  348. 338.
    McNutt MA, Bolen JW. Adenomatous tumor of the middle ear. Am J Clin Pathol 1985; 84: 541–547.PubMedGoogle Scholar
  349. 339.
    Bussolati G, Gugliotta P. Sapino A, Eusebi V, Lloyd R. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) from normal tissue of the breast. Am J Pathol 1985; 120: 186–192.PubMedGoogle Scholar
  350. 340.
    O’Connor DT, Deftos LJ. ecretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986; 314: 1145–1151.PubMedCrossRefGoogle Scholar
  351. 341.
    Lloyd RV, Sisson JC, Shapiro B, Verhofstad AAJ. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes and chromogranin in neuroendocrine cells and tumors. Am J Pathol 1986; 125: 45–54.PubMedGoogle Scholar
  352. 342.
    Banks P, Helle K. The release of protein from the stimulated adrenal medulla. Biochem J 1965; 97: 40C - 41C.PubMedGoogle Scholar
  353. 343.
    Angeletti RH. Chromogranins and neuroendocrine secretion. Lab Invest 1986; 55: 387–390.PubMedGoogle Scholar
  354. 344.
    Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984; 115: 458–468.PubMedGoogle Scholar
  355. 345.
    Lauweryns JM, vanRanst K, Lloyd RV, et al. Chromogranin in bronchopulmonary neuroendocrine cells: Immunohistochemical detection in human, monkey and pig respiratory mucosa. J Histochem Cytochem 1987; 35: 113–118.PubMedCrossRefGoogle Scholar
  356. 346.
    Mukai M, Torikata C, Iri H, et al. Expression of neurofilament triplet proteins in human neural tumor: An immunohistochemical study of paraganglioma, ganglioneuroma, ganglioneuroblastoma and neuro-blastoma. Am J Pathol 1986; 122: 28–36.PubMedGoogle Scholar
  357. 347.
    Shah IA, Schlageter M, Netto D. Immunoreactivity of neurofilament proteins in neuroendocrine neoplasms. Mod Pathol 1991; 4: 215–219.PubMedGoogle Scholar
  358. 348.
    Leoncini P, DeMarco EB, Bugnoli M. Mencarelli C, Vindigni C, Cintorino M. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors. Pathol Res Pract 1989; 185: 848–855.PubMedCrossRefGoogle Scholar
  359. 349.
    Jahn B, Schibler W, Ouimet C, et al. A 38,000 dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 1985; 82: 4137–4141.PubMedCrossRefGoogle Scholar
  360. 350.
    Gould VE, Lee I, Wiedenmann B, Moll R, Chejfec G, Franke WW. Synaptophysin: A novel marker for neurons, certain neuroendocrine cells and their neoplasms. Hum Pathol 1986; 17: 979–983.PubMedCrossRefGoogle Scholar
  361. 351.
    Bunn P, Linnoila I, Minna J, Carney D, Gazdar AF. Small cell cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express Leu7 antigenic determinant present on natural killer cells. Blood 1985; 65: 764–768.PubMedGoogle Scholar
  362. 352.
    Tsutsumi Y. Leu7 immunoreactivity as a histochemical marker for paraffin-embedded neuroendocrine tumors. Acta Histochem Cytochem 1984; 17: 15.CrossRefGoogle Scholar
  363. 353.
    Tischler AS, Mobtaker H, Mann K, et al. Anti-lymphocyte monoclonal antibody HNK-1 (Leu7) recognizes a constituent of neuroendocrine matrix. Lab Invest 1986; 54: 64A.Google Scholar
  364. 354.
    Komminoth P, Roth J, Lackie PM, Bitter-Suermann D, Heitz PU. Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 1991; 139: 297–304.PubMedGoogle Scholar
  365. 355.
    Kibbelaar RE, Moolenaar CEC, Michalides RJAM, Bitter-Suermann D, Addis BJ, Mooi WJ. Expression of the embryonal neural cell adhesion molecular N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer. J Pathol 1989; 159: 23–28.PubMedCrossRefGoogle Scholar
  366. 356.
    Moolenaar CE, Muller EJ, Schol DJ, Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer, and neuroblastoma cell lines H69 and CHP-212. Cancer Res 1990; 50: 1102–1106.PubMedGoogle Scholar
  367. 357.
    Kahn HJ, Garrido A, Huang S-N, Baumal R. Intermediate filaments and tumor diagnosis. Lab Invest 1983; 49: 509.Google Scholar
  368. 358.
    Lehto V-P, Stenman S, Miettinen M, Dahl D, Virtanen I. Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol 1983; 110: 113–118.PubMedGoogle Scholar
  369. 359.
    VanMuijen GNP, Ruiter DJ, Leeuwen CV, Prins FA, Rietsema K, Warnaar SO. Cytokeratin and neurofilament in lung carcinomas. Am J Pathol 1984; 116: 363–369.Google Scholar
  370. 360.
    Lehto V-P, Miettinen M, Dahl D, Virtanen I. Bronchial carcinoid cells contain neural-type intermediate filaments. Cancer (Philadelphia) 1984; 54: 624–628.CrossRefGoogle Scholar
  371. 361.
    Clark RK, Miettinen M, Leij L, Damjanov I. Terminally differentiated derivatives of pulmonary small cell carcinomas may contain neurofilaments. Lab Invest 1985; 53: 243–244.PubMedGoogle Scholar
  372. 362.
    Broers J, Huysmans A, Moesker O, Vooijs P, Ramaekers F, Wagenaar S. Small cell lung cancer contains intermediate filaments of the cytokeratin type. Lab Invest 1985; 52: 113–114.PubMedGoogle Scholar
  373. 363.
    Moll R, Franke WW, Schiller DL, et al. The catalogue of human cytokeratins. Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11–24.PubMedCrossRefGoogle Scholar
  374. 364.
    Cooper D, Schermer A, Sun T-T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations. Lab Invest 1985; 52: 243–256.PubMedGoogle Scholar
  375. 365.
    Gown AM, Gabbiani G. Intermediate-sized (10-nm) filaments in human tumors. In: DeLellis, RA, ed. Advances in immunohistochemistry. New York: Masson, 1984: 89–109.Google Scholar
  376. 366.
    Miettinen M, Lehto V-P, Virtanen I. Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastruct Pathol 1984; 7: 83–107.PubMedCrossRefGoogle Scholar
  377. 367.
    Moll R, Cowin P, Kapprell H-P, Franke WW. Desmosomal proteins: New markers for identification and classification of tumors. Lab Invest 1986; 54: 4–25.PubMedGoogle Scholar
  378. 368.
    Funa K, Gazdar AF, Minna JD, Linnoila RI. Paucity of B2-microglobulin expression on small cell lung cancer, bronchial carcinoids, and certain other neuroendocrine tumors. Lab Invest 1986; 55: 186–192.PubMedGoogle Scholar
  379. 369.
    Payne CM, Nagle RB, Borduin V. Methods in laboratory investigation: an ultrastructural cytochemical stain specific for neuroendocrine neoplasms. Lab Invest 1984; 51: 350–365.PubMedGoogle Scholar
  380. 370.
    Nagle RB, Payne CM, Clark VA. Comparison of the usefulness of histochemistry and ultrastructural cytochemistry in the identification of neuroendocrine neoplasms. Am J Clin Pathol 1986; 85: 289–296.PubMedGoogle Scholar
  381. 371.
    Gould VE, Benditt EP. Ultrastructural and functional relationships of some human endocrine tumors. Pathol Annu 1973; 8: 205–230.PubMedGoogle Scholar
  382. 372.
    Gould VE. Neuroendocrinomas and neuroendocrine carcinomas: APUD-cell system neoplasms and their aberrant secretory activities. Pathol Annu 1977; 12 (Part 2): 33–62.Google Scholar
  383. 373.
    Sunday ME, Choi N, Spindel ER, Chin WW, Mark EJ. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated carcinomas. Hum pathol 1991; 22: 1030–1039.PubMedCrossRefGoogle Scholar
  384. 374.
    Hamid Q, Corrin B, Sheppard MN, Polak JM. Localization of chromogranin mRNA in small cell carcinoma of the lung. J Pathol 1991; 163: 293–297.PubMedCrossRefGoogle Scholar
  385. 375.
    Frohlich F. Die ‘Helle Zelle’ der Bronchialschleimhaut and ihre Beziehungen zum Problem der Chemoreceptoren. Frankfurt Ztschr Z Pathol 1949; 60: 517–559.Google Scholar
  386. 376.
    Feyrter F. Zur Pathologie des argyrophilen Helle-ZellOrganes im Bronchialbaum des Menschen. Virchows Arch 1954; 325: 723–732.PubMedCrossRefGoogle Scholar
  387. 377.
    Bensch KG, Gordon GB, Miller LR. Studies on the bronchial counterpart of the Kultschitzky (argentaffin) cell and innervation of bronchial glands. J Ultrastruct Res 1965; 12: 668–686.PubMedCrossRefGoogle Scholar
  388. 378.
    Bensch KG, Gordon GB, Miller LR. Electron microscopic and biochemical studies on the bronchial carcinoid tumor. Cancer 1965; 18: 592–602.PubMedCrossRefGoogle Scholar
  389. 379.
    Gmelich JT, Bensch KG, Liebow AA. Cells of Kultchitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor. Lab Invest 1967; 17: 88–98.PubMedGoogle Scholar
  390. 380.
    Lauweryns JM, Cokelaere M. Theunynck PK. Neuroepithelial bodies in the respiratory mucosa of various mammals: a light optical, histochemical, and ultrastructural investigation. Z Zellforsch Mikrosk Anat 1972; 135: 569–592.PubMedCrossRefGoogle Scholar
  391. 381.
    Lauweryns JM, Goddeeris P. Neuroepithelial bodies in the human child and adult lung. Am Rev Respir Dis 1975; 111: 469–476.PubMedGoogle Scholar
  392. 382.
    Johnson DE, Loch JE, Elde RP, Thompson TR. Pulmonary neuroendocrine cells in bronchopulmonary dysplasia and hyaline membrane disease. Pediatr Res 1982;16:446–454.Google Scholar
  393. 383.
    Johnson DE, Wobken JD, Landrum BG. Changes in bombesin, calcitonin and serotonin immunoreactive pulmonary neuroendocrine cells in cystic fibrosis and after prolonged mechanical ventilation. Am Rev Respir Dis 1988; 137: 123–131.PubMedCrossRefGoogle Scholar
  394. 384.
    Stahlman MT, Gray ME. Ontogeny of neuroendocrine cells in human fetal lung. I. An electron microscopic study. Lab Invest 1984; 51: 449–463.PubMedGoogle Scholar
  395. 385.
    Stahlman MT, Kasselberg AG, Orth DN, Gray ME. Ontogeny of neuroendocrine cells in human feta lung. II. An immunohistochemical study. Lab Invest 1985; 52: 52–60.PubMedGoogle Scholar
  396. 386.
    Spindel ER, Sunday ME, Hoffer H, Wolfe HJ, Habener JF, Chin WW. Transient elevation of messenger RNA encoding gastrin releating peptide, a putative pulmonary growth factor in human fetal lung. J Clin Invest 1987; 80: 1172–1179.PubMedCrossRefGoogle Scholar
  397. 387.
    Sobol RE, O’Connor DT, Addison J, Suchocki K, Royston I, Deftos U. Elevated serum chromogranin A levels in small cell lung carcinoma. Ann Intern Med 1986; 1095: 698–700.CrossRefGoogle Scholar
  398. 388.
    Gosney JR, Sissons MCJ, Allibone RO, Blakely AF. Pulmonary endocrine cells in chronic bronchitis and emphysema. J Pathol 1989; 157: 127–133.PubMedCrossRefGoogle Scholar
  399. 389.
    Aguayo SM, King TE, Jr., Waldron JA, Jr., Sherritt KM, Kane MA, Miller YE. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adults with eosinophilic granuloma. J Clin Invest 1989; 86: 838–844.CrossRefGoogle Scholar
  400. 390.
    Aguayo SM, Kane MA, King TE, Jr., Schwarz MI, Graver L, Miller YE. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest 1989; 84: 1105–1113.PubMedCrossRefGoogle Scholar
  401. 391.
    Tabassian AR, Nylen ES, Linnoila RI, Snider RH, Cassidy MM, Becker KL. Stimulation of hamster pulmonary neuroendocrine cells and associated peptides by repeated exposure to cigarette smoke. Am Rev Respir Dis 1989; 140: 436–440.PubMedCrossRefGoogle Scholar
  402. 392.
    Aguayo SM, Miller YE, Waldron JA, Jr., et al. Brief report: Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992; 327: 1285–1288.PubMedCrossRefGoogle Scholar
  403. 393.
    Benfield JR. Neuroendocrine neoplasms of the lung. J Thorac Cardiovasc Surg 1990; 100: 628–629.PubMedGoogle Scholar
  404. 394.
    Whitwell F. Tumorlets of the lung. J Pathol Bacteriol 1955; 70: 529–541.PubMedCrossRefGoogle Scholar
  405. 395.
    Churg A, Warnock ML. Pulmonary tumorlet: A form of peripheral carcinoid. Cancer (Philadelphia) 1976; 37: 1469–1477.CrossRefGoogle Scholar
  406. 396.
    Miller MA, Mark J, Kanarek D. Multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type, with restrictive and obstructive lung disease. Am J Med 1978; 65: 373–378.PubMedCrossRefGoogle Scholar
  407. 397.
    Pelosi G, Zancanaro C, Sbubo L, Bresaola E, Martignoni G, Bontempini L. Development of innumerable neuroendocrine tumorlets in pulmonary lobe scarred by intralobular sequestration: Immunohistochemical and ultrastructural study of an unusual case. Arch Pathol Lab Med 1992; 116: 1167–1174.PubMedGoogle Scholar
  408. 398.
    D’Aggti VD, Perzin KH. Carcinoid tumorlets of the lung with metastasis to a peribronchial lymph node: report of a case and review of the literature. Cancer (Philadelphia) 1985; 55: 2472–2476.CrossRefGoogle Scholar
  409. 399.
    Mueller H. Zur Untersuchungsgeschichte der bronchialen Weiterungen. Inaug Diss Halle, 1882.Google Scholar
  410. 400.
    Kramer R. Adenoma of bronchus. Ann Otol Rhinol Laryngol 1930; 39: 689–695.Google Scholar
  411. 401.
    Hamper] H. Über gutartige Bronchialtumoren. Virchows Arch [Pathol Anat] 1937; 300: 1937: 46–88.Google Scholar
  412. 402.
    Oberndorfer S. Karzinoide Tumoren des Diinndarms. Frankfurt Zeitschr Pathol 1907;1:426–432.Google Scholar
  413. 403.
    Briselli M, Mark GJ, Grillo HC. Tracheal carcinoids. Cancer (Philadelphia) 1978; 42: 2870–2879.CrossRefGoogle Scholar
  414. 404.
    Bonikos DS, Bensch KG, Jamplis RW. Peripheral pulmonary carcoinoid tumors. Cancer (Philadelphia) 1976; 37: 1977–1998.CrossRefGoogle Scholar
  415. 405.
    Felton WL, Liebow AA, Lindskog GE. Peripheral and multiple bronchial adenomas. Cancer (Philadelphia) 1953; 6: 555–567.CrossRefGoogle Scholar
  416. 406.
    Skinner C, Ewen SWB. Carcinoid lung: diffuse pulmonary infiltration by a multifocal bronchial carcinoid. Thorax 1976; 31: 212–219.PubMedCrossRefGoogle Scholar
  417. 407.
    Abdi EA, Goel R, Bishop S, Bain GO. Peripheral carcinoid tumours of the lung: A clinicopathological study. J Surg Oncol 1988; 39: 190–196.PubMedCrossRefGoogle Scholar
  418. 408.
    Carter D, Eggleston JC, Carcinoid tumors. In: Tumors of the lower respiratory tract. Atlas of tumor pathology, 2d Ser., Fasc. 17. Washington, DC: Armed Forces Institute of Pathology, 1980: 162–188.Google Scholar
  419. 409.
    Mark EJ, Quay SC, Dickensin GR. Papillary carcinoid tumor of the lung. Cancer (Philadelphia) 1981; 48: 316324.Google Scholar
  420. 410.
    Ranchod M, Levine GD. Spindle cell carcinoid tumors of the lung: A clinicopathologic study of 35 cases. Am J Surg Pathol 1980; 4: 315–331.PubMedCrossRefGoogle Scholar
  421. 411.
    Sklar JL, Churg A, Bensch KG. Oncocytic carcinoid tumor of the lung. Am J Surg Pathol 1980; 4: 287–292.PubMedCrossRefGoogle Scholar
  422. 412.
    Sajjad SM, Mackay B, Lukeman JM. Oncocytic carcinoid tumor of the lung. Ultrastruct Pathol 1980; 1: 17 1176.Google Scholar
  423. 413.
    Scharifker D, Marchevsky A. Oncocytic carcinoid of lung: an ultrastructural analysis. Cancer (Philadelphia) 1981; 47: 530–532.CrossRefGoogle Scholar
  424. 414.
    Ghadially FN, Block HJ. Oncocytic carcinoid of the lung. J Submicrosc Cytol 1985; 17: 435–442.PubMedGoogle Scholar
  425. 415.
    Santos-Briz, Terron J, Sastre R, Romero L, Valle A. Oncocytoma of the lung. Cancer 1977; 40: 1330–1336.Google Scholar
  426. 416.
    Cebelin MS. Melanocytic bronchial carcinoid tumor. Cancer (Philadelphia) 1980; 46: 1843–1848.CrossRefGoogle Scholar
  427. 417.
    Grazer R, Cohen SM, Jacobs JB, Lucas P. Melanin-containing peripheral carcinoid of the lung. Am J Surg Pathol 1982; 6: 73–78.PubMedCrossRefGoogle Scholar
  428. 418.
    Carlson JA, Dickersin GR. Melanocytic paraganglioid carcinoid tumor: A case report and review of the literature. Ultrapathol (in press).Google Scholar
  429. 419.
    Barbareschi M, Frigo B, Mosca L, et al. Bronchial carcinoids with 5 100 positive sustenatacular cells. Pathol Res Pract 1990; 186: 212–217.PubMedCrossRefGoogle Scholar
  430. 420.
    Capella C, Gabrielli M, Polak JM, Buffa R, Solcia E. Ultrastructural and histological study of 11 bronchial carcinoids. Virchows Arch Pathol Anat [A] 1979; 381: 313–329.Google Scholar
  431. 421.
    Barbareschi M, Frigo B, Cristina S, Valentini L, Leon-ardi E, Mosca L. Bronchial carcinoid with paranuclear fibrillary inclusions related to cytokeratins and vimentin. Virchows Arch [A] Pathol Anat 1989; 415: 31–36.CrossRefGoogle Scholar
  432. 422.
    Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972; 64: 413–421.PubMedGoogle Scholar
  433. 423.
    Leschke H. Über nur regionär bösartige and über krebsig entartete Bronchusadenome bzw. Carcinoide. Virchows Arch [Path Anat] 1956; 328: 635–657.CrossRefGoogle Scholar
  434. 424.
    Warren WH, Memoli VA, Gould VE. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. II. Well-differentiated neuroendocrine carcinomas. Ultrastruct Pathol 1984; 7: 185–199.PubMedCrossRefGoogle Scholar
  435. 425.
    Mark EJ, Ramirez JF. Peripheral small-cell carcinoma of the lung resembling carcinoid tumor: A clinical and pathologic study of 14 cases. Arch Pathol Lab Med 1985; 109: 263–269.PubMedGoogle Scholar
  436. 426.
    Paladugu RR, Benfield JR, Pak HY, Ross RK, Teplitz RL. Bronchopulmonary kulchitzky cell carcinomas. Cancer (Philadelphia) 1985; 55: 1303–1311.CrossRefGoogle Scholar
  437. 427.
    Tsutsumi Y, Yazaki K, Yoshioka K. Atypical carcinoid tumor of the lung, associated with giant cell transformation in bone metastases.Google Scholar
  438. 428.
    Hammar S, Bockus D, Remington F, Cooper L. The unusual spectrum of neuroendocrine lung neoplasms. Ultra Pathol 1989; 13 (5,6): 515–560.CrossRefGoogle Scholar
  439. 429.
    Gould VE, Chejfec G. Ultrastructural and biochemical analysis of pulmonary “undifferentiated” carcinomas. Hum Pathol 1978; 9: 377–384.PubMedCrossRefGoogle Scholar
  440. 430.
    McDowell EM, Wilson TS, Trump BF. Atypical endocrine tumors of the lung. Arch Pathol Lab Med 1981; 105: 20–28.PubMedGoogle Scholar
  441. 431.
    Hammond ME, Sause WT. Large cell neuroendocrine tumors of the lung: Clinical significance and histopathologic definition. Cancer (Philadelphia) 1985; 56: 1624–1629.CrossRefGoogle Scholar
  442. 432.
    Neal MH, Kosinki R, Cohen P, Orenstein JM. Atypical endocrine tumors of the lung: a histologic, ultrastructural and clinical study of 19 cases. Hum Pathol 1986; 17: 1264–1277.PubMedCrossRefGoogle Scholar
  443. 433.
    Barbareschi M, Mariscotti C, Barberis M, Frigo B, Mosca L. Large cell neuroendocrine carcinoma of the lung. Tumori 1989; 75: 583–588.PubMedGoogle Scholar
  444. 434.
    Travis WD, Linnoila I, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma: An ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol 1991; 15: 529–533.PubMedCrossRefGoogle Scholar
  445. 435.
    Wick MR, Berg LC, Hertz MI. Large cell carcinoma of the lung with neuroendocrine differentiation; a comparison with large cell “undifferentiated” pulmonary tumors. Am J Clin Pathol 1992; 987: 796–805.Google Scholar
  446. 436.
    Mooi WJ, Dewar A, Springall D, Polak JM, Addis BJ. Non-small cell lung carcinomas with neuroendocrine features: A light microscopic, immunohistochemical and ultrastructural study of 11 cases. Histopathology 1988; 13: 329–337.PubMedCrossRefGoogle Scholar
  447. 437.
    Vosika GJ. Large cell bronchogenic carcinoma: Prolonged disease-free survival following chemotherapy. JAMA 1979; 241: 594–595.PubMedCrossRefGoogle Scholar
  448. 438.
    Gibbs FA. Lymphoma versus carcinoma. JAMA 1979; 242: 514.PubMedCrossRefGoogle Scholar
  449. 439.
    Vosika GJ. Large cell-small cell bronchogenic carcinoma. JAMA 1979; 242: 1259–1260.CrossRefGoogle Scholar
  450. 440.
    Bernard WG. The nature of the “oat-celled sarcoma” of the mediastinum. J Pathol Bacteriol 1926; 29: 241–244.CrossRefGoogle Scholar
  451. 441.
    Gibbon JH Jr, Nealon TF Jr. Neoplasms of the lungs and trachea. In: Gibbon JH Jr, ed. Surgery of the chest. Philadelphia: Saunders, 1962: 484.Google Scholar
  452. 442.
    Azzopardi JG. Oat-cell carcinoma of the bronchus. J Pathol Bacteriol 1959; 78: 513–519.PubMedCrossRefGoogle Scholar
  453. 443.
    Yesner R. Small cell tumors of the lung. Am J Surg Pathol 1983; 7: 775–785.PubMedGoogle Scholar
  454. 444.
    Carter D. Small-cell carcinoma of the lung. Am J Surg Pathol 1983; 7: 787–795.PubMedGoogle Scholar
  455. 445.
    Yesner R. Classification of long-cancer histology. N Engl J Med 1985; 312: 652–653.PubMedGoogle Scholar
  456. 446.
    Stuart-Harris R, Boyer M, Greenberg M, Stevens S, Yung T. The histopathological classification of small cell lung cancer: Application of the IASLC classification in 124 cases. Lung Cancer 1992; 8: 63–70.CrossRefGoogle Scholar
  457. 447.
    Gazdar AF, Carney DN, Baylin SB, et al. Small cell carcinoma of the lung. Altered morphological, biological and biochemical characteristics in long term cultures and heterotransplanted tumors. Proc Am Assoc Cancer Res 1980; 21: 51.Google Scholar
  458. 448.
    Fushimi H, Kihui M, Morino H, et al. Detection of large cell component in small cell lung carcinoma by combined cytologic and histologic examinations and its clinical implications. Cancer (Philadelphia) 1992; 70: 599–605.CrossRefGoogle Scholar
  459. 449.
    Visscher DW, Zarbo RJ, Trojanowski JQ, Sakr W, Crissman JD. Neuroendocrine differentiation in poorly-differentiated lung carcinomas: a light microscopic and immunohistologic study. Mod Pathol 1990; 3: 508–512.PubMedGoogle Scholar
  460. 450.
    Linnoila RI, Mulshine JL, Steinberg SM, et al. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 1988; 90: 641–652.PubMedGoogle Scholar
  461. 451.
    Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer (Philadelphia) 1985; 56: 2107–2111.CrossRefGoogle Scholar
  462. 452.
    Andersen HA, Bernatz PE. Extrathoracic manifestations of bronchogenic carcinoma. Med Clin N Am 1964; 48: 921–931.PubMedGoogle Scholar
  463. 453.
    Mountain CF, Lukeman JM, Hammar S, et al. Lung cancer classification: The relationship of disease extent and cell type to survival in a trial population. J Surg Oncol 1987; 35: 147–156.PubMedCrossRefGoogle Scholar
  464. 454.
    Okike N, Bernatz PE, Woolner LB. Carcinoid tumors of the lung. Ann Thorac Surg 1976; 22: 270–275.PubMedCrossRefGoogle Scholar
  465. 455.
    Brandt B, Heintz SE, Rose EF, Ehrenhaft JL. Bronchial carcinoid tumors. Ann Thorac Surg 1984; 38: 63–65.PubMedCrossRefGoogle Scholar
  466. 456.
    McCaughan BC, Martini N, Bains MS. Bronchial carcinoids: Review of 124 cases. J Thorac Cardiovasc Surg 1985; 89: 8–17.PubMedGoogle Scholar
  467. 457.
    Thunnissen FBJM, van Eijk J, Baak JPA, Schipper NW, Uyterlinde AM, Breederveld RS, Meijer S. Bronchopulmonary carcinoids and regional node metastases: a quantitative pathologic investigation. Am J Pathol 1988; 132: 119–122.PubMedGoogle Scholar
  468. 458.
    Warren WH, Gould VE. Long-term follow-up of classical bronchial carcinoid tumors. Scan J Thor Cardiovasc Surg 1990; 24: 125–130.CrossRefGoogle Scholar
  469. 459.
    El-Naggar A, Ballance W, Abdu Karim FW, Ordonez NG, McLemore D, Giacco GG, Batsakis JG. Typical and atypical bronchopulmonary carcinoids: A clinico-pathologic and flow cytometric study. Am J Clin Pathol 1991; 95: 828–834.PubMedGoogle Scholar
  470. 460.
    Yousem SA, Taylor SR. Typical and atypical carcinoid tumors of lung: A clinicopathologic and DNA analysis of 20 tumors. Mod Pathol 1990; 3: 502–507.PubMedGoogle Scholar
  471. 461.
    Bernstein C, McGoey J, Lertzman M. Recurrent bronchial carcinoid tumor. Chest 1989; 95: 693–694.PubMedCrossRefGoogle Scholar
  472. 462.
    Greengard O, Head JF, Goldberg SL, Kirschner PA. Pulmonary carcinoid tumors: Enzymic discriminants, growth rate and early age of inception. Cancer Res 1986; 46: 2600–2605.PubMedGoogle Scholar
  473. 463.
    Yousem SA. Pulmonary carcinoid tumors and well differentiated neuroendocrine carcinomas: Is there room for atypical carcinoid? Am J Cln Pathol 1991; 95: 828–834.Google Scholar
  474. 464.
    Warren WH, Memoli VA, Jordan AG, Gould VE., Reevaluation of pulmonary neoplasms as small cell neuroendocrine carcinomas. Cancer 1990; 65: 1003 1010.Google Scholar
  475. 465.
    Larsimont D, Kiss R, deLaunoit Y, Melamed MR. Characterization of the morphonuclear features and DNA ploidy of typical and atypical carcinoids and small cell cell carcinomas of the lung. Am J Clin Pathol 1990; 94: 378–373.PubMedGoogle Scholar
  476. 466.
    Lequaglie C, Patriarca C, Cataldo I, Muscolino G, Preda F, Ravasi G. Prognosis of resected well-differentiated neuroendocrine carcinoma of the lung. Chest 1991; 100: 1053–1056.PubMedCrossRefGoogle Scholar
  477. 467.
    Memoli VA. Well-differentiated neuroendocrine carci-noma: A designation comes of age. Chest 1991; 100: 892.PubMedCrossRefGoogle Scholar
  478. 468.
    Jackson-York GL, Davis GH, Warren WH, Gould VE, Memoli VA. Flow cytometric DNA content analysis in neuroendocrine carcinoma of the lung: Correlation with survival and histologic subtype. Cancer (Philadelphia) 1991; 68: 374–379.CrossRefGoogle Scholar
  479. 469.
    Quoix E, Fraser R, Wolkove N, Finkelstein H, Kreis-man H. Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer (Philadelphia) 1990; 66: 577–582.CrossRefGoogle Scholar
  480. 470.
    Kreisman H, Wolkove N, Quoix E. Small cell lung cancer presenting as a solitary pulmonary nodule. Chest 1992; 101: 225–229.PubMedCrossRefGoogle Scholar
  481. 471.
    Shepherd FA, Ginsberg R, Evans WK, Haddad R, Feld R, DeBoer G. “Very limited” small cell lung cancer: Results of nonsurgical treatment. Proc Am Soc Clin Oncol 1984; 3: 223–228.Google Scholar
  482. 472.
    Gephardt GN, Grady KJ, Ahmad M, Tubbs RR, Mehta ACI, Shepard KV. Peripheral small cell undifferentiated carcinoma of the lung: Clinicopathologic features of 17 cases. Cancer (Philadelphia) 1988; 61: 1002–1008.CrossRefGoogle Scholar
  483. 473.
    Fraire AE, Johnson EH, Yesner R, Zhang XB, Spjut HJ, Greenberg SD. Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol 1992; 23: 520–528.PubMedCrossRefGoogle Scholar
  484. 474.
    Bepler G, Neumann K, Holle R, Havemann K, Kalbfleisch H. Clinical relevance of histologic subtyping in small cell lung cancer. Cancer (Philadelphia) 1989; 64: 74–79.CrossRefGoogle Scholar
  485. 475.
    Crown JPA, Chahinian AP, Jaffrey IS, Glidewell OJ, Kaneko M, Holland JR. Predictors of 5-year survival and curability in small cell lung cancer. Cancer (Philadelphia) 1990; 66: 382–386.CrossRefGoogle Scholar
  486. 476.
    Albain KS, Crowley JJ, Livingston RB. Long-term survival and toxicity in small cell lung cancer: Expanded Southwest Oncology Group experience. Chest 1991; 99: 1425–1432.PubMedCrossRefGoogle Scholar
  487. 477.
    Oud PS, Pahlplatz MM, Beck LM, Wiersma-Van Tilburg A, Wagenaar SJ, Vooijs GP. Cancer (Philadelphia) 1989; 64: 1304–1309.CrossRefGoogle Scholar
  488. 478.
    Funa K, Steinholtz L, Nov E, Bergh J. Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy. Am J Clin Pathol 1987; 88: 216–220.PubMedGoogle Scholar
  489. 479.
    Copple B, Wright SE, Moatamed F. Electron microscopy in small cell lung carcinomas: Clinical correlation. J Clin Oncol 1984; 2: 910–916.PubMedGoogle Scholar
  490. 480.
    Vollmer RT, Shelburne JD, Iglehart JD. Intercellular junctions and tumor stage in small cell carcinoma of the lung. Hum Pathol 1986; 18: 22–27.CrossRefGoogle Scholar
  491. 481.
    Elson CE, Roggli VL, Vollmer RT, Greenberg SD, Fraire AE, Spjut HJ, Yesner R. Prognostic indicators for survival in stage I carcinoma of the lung: A histologic study of 47 surgically resected cases. Mod Pathol 1988; 1: 288–291.Google Scholar
  492. 482.
    Shahab I, Fraire AE, Greenberg SD, Johnson EH, Langston C, Roggli VL. Morphometric quantitation of tumor necrosis in stage I non-small cell carcinoma of lung: Prognostic implications. Mod Pathol 1992; 5: 521–524.PubMedGoogle Scholar
  493. 483.
    Cagle PT, Langston C, Fraire AE, Roggli VL, Greenberg SD. Absence of correlation between nuclear morphometry and survival in stage I non-small cell lung carcinoma. Cancer (Philadelphia) 1992; 69: 2454–2457.CrossRefGoogle Scholar
  494. 484.
    Gallagher B, Urbanski SJ. The significance of pleural elastica invasion by lung carcinomas. Hum Pathol 1990; 21: 512–517.PubMedCrossRefGoogle Scholar
  495. 485.
    Ratto GB, Frola C, Sacco G, Motta G. The prognostic significance of minor pleural effusions in patients with potentially operable bronchogenic carcinoma. Lung Cancer 1987; 3: 117–122.CrossRefGoogle Scholar
  496. 486.
    Yoshimoto T, Higashino K, Hada T, et al. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen and human chorionic-gonadotropin. Cancer (Philadelphia) 1987; 60: 2744–2750.CrossRefGoogle Scholar
  497. 487.
    Kuida CA, Braunstein GD, Shintaku P, Said JW. Human chorionic-gonadotropin expression in lung, breast, and renal carcinomas. Arch Pathol Lab Med 1988; 112: 282–285.PubMedGoogle Scholar
  498. 488.
    Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Res 1985; 45: 4206–4214.PubMedGoogle Scholar
  499. 489.
    Baltifora H, Sorensen HR, Mehta P, et al. Tumor-associated antigen 43–9F is of prognostic value in squamous cell carcinoma of the lung. Cancer 1992; 70: 1867–1872.CrossRefGoogle Scholar
  500. 490.
    Poulakis N. Sarandakou S, Rizos D, Phocas I, Kontozoglou T, Polyzogopoulos D. Soluble interleukin-2-receptors and other markers in primary lung cancer. Cancer (Philadelphia) 1991; 68: 1045–1049.CrossRefGoogle Scholar
  501. 491.
    Miyake M, Taki T, Hitomi S, Hakomori S. Correlation of expression of H/Le-y/Le-b antigens with survival in patients with carcinoma of the lung. N Engl J Med 1992; 327: 14–18.PubMedCrossRefGoogle Scholar
  502. 492.
    Buccheri G, Ferrigno D. Prognostic value of the tissue polypetide antigen in lung cancer. Chest 1992; 101: 1287–1292.PubMedCrossRefGoogle Scholar
  503. 493.
    Cline MJ, Battifora H. Abnormalities of protooncogenes in non-small cell lung cancer: Correlations with tumor type and clinical characteristics. Cancer (Philadelphia) 1987; 60: 2669–2674.CrossRefGoogle Scholar
  504. 494.
    Harada M, Dosaka-Akita H, Miyamoto H, Kuzumaki N, Kawakami Y. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer. Cancer 1992; 69: 72–77.PubMedCrossRefGoogle Scholar
  505. 495.
    Caamano J, Ruggeri B, Momiki S, Sickler A, Zhang SY, Klein-Szanto AJP. Detection of p53 in primary lung tumors and non-small cell lung carcinoma cell lines. Am J Pathol 1991; 139: 839–845.PubMedGoogle Scholar
  506. 496.
    Porter PL, Gown AM, Kramp SG, Coltrea MD. Widespread p53 overexpression in human malignant tumors: An immunohistochemical study using methacam-fixed, embedded tissue. Am J Pathol 1992; 140: 145–152.PubMedGoogle Scholar
  507. 497.
    Slebos RJC, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323: 561–565.PubMedCrossRefGoogle Scholar
  508. 498.
    ten Velde GPM, Havenith MG. Volovics A, Bosman FT. Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer (Philadelphia) 1991; 67: 3001–3005.CrossRefGoogle Scholar
  509. 499.
    Nagamoto N, Saito Y, Ohta S. Relationship of lymph node metastasis to primary tumor size and microscopic appearance of roentgenographically occult lung cancer. Am J Surg Pathol 1989; 13: 1009–1013.PubMedCrossRefGoogle Scholar
  510. 500.
    Atsushi T, Kodama T, Shimosato Y, Watanabe S, Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer (Philadelphia) 1988; 61: 2083–2088.CrossRefGoogle Scholar
  511. 501.
    Ohori NP, Yousem SA, Griffin J, et al. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: An immunohistochemical study. Am J Surg Pathol 1992; 16: 675–686.PubMedCrossRefGoogle Scholar
  512. 502.
    Delmomte VC, Alberti O, Saldiva PHN. Large cell carcinoma of the lung-ultrastructural and immunohistochemical features. Chest 1986; 90: 524–527.CrossRefGoogle Scholar
  513. 503.
    Albain KS, True LD, Golomb HM, Hoffman PC, Little AG. Large cell carcinoma of the lung: Ultrastructural differentiation and clinicopathologic correlations. Cancer (Philadelphia) 1985; 56: 1618–1623.CrossRefGoogle Scholar
  514. 504.
    Coon JS, Landay AL, Weinstein RS. Biology of disease: Advances in flow cytometry for diagnostic pathology. Lab Invest 1987; 57: 453–479.PubMedGoogle Scholar
  515. 505.
    Wersto RP, Liblit RL, Koss LG. Flow cyctometric DNA analysis of human solid tumors: A review of the interpretation of DNA histograms. Hum Pathol 1991; 22: 1085–1098.PubMedCrossRefGoogle Scholar
  516. 506.
    Frierson HF, Jr. The need for improvement in flow cytometric analysis of ploidy and S-phase fraction. Am J Clin Pathol 1991; 96: 439–441.Google Scholar
  517. 507.
    Zimmerman PV, Bint MH, Hawson GAT, Parsons PG. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987;ii:530–533.Google Scholar
  518. 508.
    Tirindelli-Danesi D, Teodori L, Mauro F, et al. Prognostic significance of flow cytometry in lung cancer: A 5-year study. Cancer (Philadelphia) 1987; 60: 844–851.CrossRefGoogle Scholar
  519. 509.
    Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y. DNA cytofluorometric and nuclear morpho-metric analyses of lung adenocarcinoma. Cancer (Philadephia) 1989; 64: 1657–1664.CrossRefGoogle Scholar
  520. 510.
    Salvati F, Teodori L, Gagliiardi L, Signora M, Aquilini M, Storniello G. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment: Prognostic implications. Chest 1989; 96: 1092–1098.CrossRefGoogle Scholar
  521. 511.
    Carey FA, Lamb B, Bird CC. Intramural heterogeneity of DNA content in lung cancer. Cancer (Philadelphia) 1991; 64: 2266–2269.Google Scholar
  522. 512.
    Schmidt RA, Rusch VW, Piantadosi S. A flow cytometric study of non-small cell lung cancer classified as TIM,. Cancer (Philadelphia) 1992; 69: 78–85.CrossRefGoogle Scholar
  523. 513.
    Filderman AE, Silvestri GA, Gatsonis C, Lithringer DJ, Honig J, Flynn SD. Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. Am Rev Respir Dis 1992; 146: 707–710.PubMedCrossRefGoogle Scholar
  524. 514.
    Ogawa J, Tsurmi T, Inove H, Shohtsu A. Relationship between tumor DNA ploidy and regional lymph node changes in lung cancer. Cancer (Philadelphia) 1992; 69: 1688–1695.CrossRefGoogle Scholar
  525. 515.
    Ogura S, Abe S, Sukoh N, Kunikane H, Nakajima I, Inoue K, Kawakami Y. Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma. Cancer (Philadelphia) 1992; 70: 63–68.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Samuel P. Hammar

There are no affiliations available

Personalised recommendations